Language selection

Government of Canada / Gouvernement du Canada

Search

Patented Medicines For Human Use Reported to the PMPRB in 2021*

January 1 to December 31, 2021

A

AbbVie Corporation
AbbVie Corporation
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02474263 HUMIRA - 20 MG/SYRINGE adalimumab L04AB Parenteral/Solution blank Within Guidelines
02258595 HUMIRA - 40 MG/SYRINGE adalimumab L04AB Parenteral/Solution blank Within Guidelines
02312301 KALETRA 100/25 MG/TABLET lopinavir/ritonavir J05AE Oral Solid/Tablet Expired Does Not Trigger
02285533 KALETRA 200/50 MG/TABLET lopinavir/ritonavir J05AE Oral Solid/Tablet Expired Within Guidelines
02243644 KALETRA 80/20 MG/ML lopinavir/ritonavir J05AE Oral Solid/Tablet Expired Within Guidelines
02467550 MAVIRET - 100/40 MG/TABLET glecaprevir/pibrentasvir J05AP Oral Solid/Tablet blank Subj. Investigation
02495155 RINVOQ - 15 MG/TABLET upadacitinib L04AA Oral Solid/Modified release tablet blank Does Not Trigger
02520893 RINVOQ - 30 MG/TABLET upadacitinib L04AA Oral Solid/Modified release tablet Introduced Under Review
02487454 SKYRIZI - 75 MG/SYRINGE risankizumab L04AC Parenteral/Solution blank Within Guidelines
02438372 SYNAGIS - 50 MG/VIAL palivizumab J06BB Parenteral/Solution blank Within Guidelines
02438364 SYNAGIS - 100 MG/VIAL palivizumab J06BB Parenteral/Solution blank Within Guidelines
02458039 VENCLEXTA - 10 MG/TABLET venetoclax L01XX Oral Solid/Tablet blank Within Guidelines
02458047 VENCLEXTA - 50 MG/TABLET venetoclax L01XX Oral Solid/Tablet blank Does Not Trigger
02458055 VENCLEXTA - 100 MG/TABLET venetoclax L01XX Oral Solid/Tablet blank Within Guidelines
02458063 VENCLEXTA 10/50/100 venetoclax L01XX Oral Solid/Tablet blank Subj. Investigation
Advanced Accelerator Applications
Advanced Accelerator Applications
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02490005 NETSPOT - 40 MCG/VIAL oxodotreotide V09I Parenteral/Solution blank Does Not Trigger
Aerie Pharmaceuticals Inc.
Aerie Pharmaceuticals Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
RHOPRESSA - 0.2 MG/ML netarsudil S01EX Ophthalmic/Solution blank Within Guidelines
Alexion Pharmaceuticals Inc.
Alexion Pharmaceuticals Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02469596 KANUMA - 2 MG/ML sebelipase alfa A16AB Parenteral/Solution Expired Within Guidelines
02322285 SOLIRIS - 10 MG/ML eculizumab L04AA Parenteral/Solution blank Subject to Stay Order
02444615 STRENSIQ - 18 MG/VIAL asfotase alfa A16AB Parenteral/Solution blank Within Guidelines
02444623 STRENSIQ - 28 MG/VIAL asfotase alfa A16AB Parenteral/Solution blank Within Guidelines
02444631 STRENSIQ - 40 MG/VIAL asfotase alfa A16AB Parenteral/Solution blank Within Guidelines
02444658 STRENSIQ - 80 MG/VIAL asfotase alfa A16AB Parenteral/Solution blank Within Guidelines
ALK-Abelló A/S
ALK-Abelló A/S
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02418304 GRASTEK - 2800 UNIT/TABLET standardized allergen extract, timothy grass (phleum pratense) V01AA Dental - Sublingual buccal/Sublingual tablet blank Within Guidelines
02498073 ITULATEK - 12 UNIT/TABLET standardized allergen extract, white birch (betula verrucosa) V01AA Oral Solid/Tablet blank Within Guidelines
02423723 RAGWITEK - 12 UNIT/TABLET standardized short ragweed pollen allerganic extract V01AA Dental - Sublingual buccal/Sublingual tablet blank Within Guidelines
Alkermes Inc.
Alkermes Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
VIVITROL - 380 MG/VIAL naltrexone N07BB Parenteral/Suspension (extended release) blank Subj. Investigation
Allergan Inc.
Allergan Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02246896 ACTONEL - 35 MG/TABLET risedronate sodium M05BA Oral Solid/Tablet Expired Within Guidelines
02316838 ACTONEL - 150 MG/TABLET risedronate sodium M05BA Oral Solid/Tablet blank Within Guidelines
02370417 ACTONEL DR - 35 MG/TABLET risedronate sodium M05BA Oral Solid/Modified release tablet blank Within Guidelines
01968300 ACULAR - 5 MG/ML ketorolac tromethamine S01BC Ophthalmic/Liquid blank Within Guidelines
02248722 ACULAR LS - 4 MG/ML ketorolac tromethamine S01BC Ophthalmic/Liquid blank Does Not Trigger
02369362 ACUVAIL - 4.5 MG/ML ketorolac tromethamine S01BC Ophthalmic/Drops blank Within Guidelines
02236876 ALPHAGAN - 2 MG/ML brimonidine tartrate S01EA Ophthalmic/Drops blank Within Guidelines
02248151 ALPHAGAN P - 1.5 MG/ML brimonidine tartrate S01EA Ophthalmic/Liquid blank Within Guidelines
01997580 ASACOL 400 - 400 MG/TABLET mesalazine A07EC Oral Solid/Modified release tablet Expired Within Guidelines
02267217 ASACOL 800 - 800 MG/TABLET mesalazine A07EC Oral Solid/Modified release tablet Expired Within Guidelines
02443910 BELKYRA - 10 MG/ML deoxycholic acid D11AX Parenteral/Solution blank Within Guidelines
01981501 BOTOX - 100 UNIT/VIAL onabotulinumtoxina M03AX Parenteral/Powder for solution blank Within Guidelines
02243721 BOTOX COSMETIC - 100 UNIT/VIAL onabotulinumtoxina M03AX Parenteral/Powder for solution blank Subj. Investigation
02248347 COMBIGAN 2/5 MG/ML brimonidine tartrate/timolol maleate S01ED Ophthalmic/Drops blank Within Guidelines
02469510 CONSTELLA - 72 MCG/CAPSULE linaclotide A06AX Oral Solid/Capsule blank Does Not Trigger
02417162 CONSTELLA - 145 MCG/CAPSULE linaclotide A06AX Oral Solid/Capsule blank Subj. Investigation
02417170 CONSTELLA - 290 MCG/CAPSULE linaclotide A06AX Oral Solid/Capsule blank Does Not Trigger
02436329 ELLA - 30 MG/TABLET ulipristal acetate G03XB Oral Solid/Tablet blank Within Guidelines
02440970 FETZIMA - 20 MG/CAPSULE levomilnacipran N06AX Oral Solid/Capsule blank Does Not Trigger
02440989 FETZIMA - 40 MG/CAPSULE levomilnacipran N06AX Oral Solid/Capsule blank Does Not Trigger
02440997 FETZIMA - 80 MG/CAPSULE levomilnacipran N06AX Oral Solid/Capsule blank Does Not Trigger
02441004 FETZIMA - 120 MG/CAPSULE levomilnacipran N06AX Oral Solid/Capsule blank Does Not Trigger
02350939 LATISSE - 0.3 MG/ML bimatoprost S01EE Topical/Liquid blank Within Guidelines
02417456 LOLO 1/0.1 norethindrone acetate/ethinyl estradiol/ethinyl estradiol G03AB Oral Solid/Tablet blank Does Not Trigger
02324997 LUMIGAN - 0.1 MG/ML bimatoprost S01EE Ophthalmic/Liquid blank Within Guidelines
02254735 OXYTROL - 36 MG/PATCH oxybutynin G04BD Topical/Patch Expired Does Not Trigger
02363445 OZURDEX - 0.7 MG/IMPLANT dexamethasone S01BA Ophthalmic/Modified release ocular device blank Within Guidelines
02361663 RAPAFLO - 4 MG/CAPSULE silodosin G04CA Oral Solid/Capsule blank Within Guidelines
02361671 RAPAFLO - 8 MG/CAPSULE silodosin G04CA Oral Solid/Capsule blank Within Guidelines
02355655 RESTASIS - 0.2 MG/VIAL cyclosporine S01XA Ophthalmic/Liquid blank Within Guidelines
02476835 RESTASIS MULTIDOSE - 0.5 MG/ML cyclosporine S01XA Ophthalmic/Liquid blank Does Not Trigger
08000454 TEFLARO - 600 MG/VIAL ceftaroline fosamil J01DI Parenteral/Powder for solution Expired Does Not Trigger
02460890 VIBERZI - 75 MG/TABLET eluxadoline A07DA Oral Solid/Tablet blank Within Guidelines
02460904 VIBERZI - 100 MG/TABLET eluxadoline A07DA Oral Solid/Tablet blank Within Guidelines
Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02506343 GIVLAARI - 189 MG/ML givosiran A16AX Parenteral/Solution blank Within Guidelines
02489252 ONPATTRO - 2 MG/ML patisiran N07XX Parenteral/Solution blank VCU
Altius Healthcare Inc.
Altius Healthcare Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02441853 PANTOPRAZOLE MAGNESIUM - 40 MG/TABLET pantoprazole magnesium A02BC Oral Solid/Tablet blank Within Guidelines
Amgen Canada Inc.
Amgen Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02459310 AMGEVITA - 20 MG/SYRINGE adalimumab L04AB Parenteral/Solution Introduced Within Guidelines
02459299 AMGEVITA - 40 MG/SYRINGE adalimumab L04AB Parenteral/Solution Introduced Within Guidelines
02459302 AMGEVITA - 40 MG/AUTO-INJECTOR adalimumab L04AB Parenteral/Solution Introduced Within Guidelines
02450283 BLINCYTO - 38.5 MCG/VIAL blinatumomab L01FX Parenteral/Powder for solution blank Within Guidelines
02242903 ENBREL - 25 MG/VIAL etanercept L04AA Parenteral/Solution blank Within Guidelines
02274728 ENBREL - 50 MG/ML etanercept L04AA Parenteral/Solution blank Within Guidelines
02489597 EVENITY - 105 MG/SYRINGE romosozumab M05BX Parenteral/Solution blank Within Guidelines
02518244 KANJINTI - 150 MG/VIAL trastuzumab L01XC Parenteral/Solution Introduced Under Review
02496690 KANJINTI - 420 MG/VIAL trastuzumab L01XC Parenteral/Powder for solution blank Within Guidelines
02459930 KYPROLIS - 10 MG/VIAL carfilzomib L01XX Parenteral/Powder for solution blank Within Guidelines
02459949 KYPROLIS - 30 MG/VIAL carfilzomib L01XX Parenteral/Powder for solution blank Within Guidelines
02451034 KYPROLIS - 60 MG/VIAL carfilzomib L01XX Parenteral/Powder for solution blank Within Guidelines
02249790 NEULASTA - 10 MG/ML pegfilgrastim L03AA Parenteral/Solution blank Within Guidelines
01968017 NEUPOGEN - 0.3 MG/ML filgrastim L03AA Parenteral/Solution blank Subj. Investigation
02420104 NEUPOGEN - 0.6 MG/ML filgrastim L03AA Parenteral/Solution blank Does Not Trigger
02420112 NEUPOGEN - 0.6 MG/ML filgrastim L03AA Parenteral/Solution blank Within Guidelines
02322854 NPLATE - 250 MCG/VIAL romiplostim B02BX Parenteral/Powder for solution blank Within Guidelines
02322862 NPLATE - 500 MCG/VIAL romiplostim B02BX Parenteral/Powder for solution blank Within Guidelines
02343541 PROLIA - 60 MG/SYRINGE denosumab M05BX Parenteral/Solution blank Within Guidelines
02459779 REPATHA - 120 MG/ML evolocumab C10AX Parenteral/Solution blank Within Guidelines
02446057 REPATHA - 140 MG/SYRINGE evolocumab C10AX Parenteral/Solution blank Within Guidelines
02513447 RIABNI - 10 MG/ML rituximab L01XC Parenteral/Solution Introduced Within Guidelines
02257130 SENSIPAR - 30 MG/TABLET cinacalcet hydrochloride H05BX Oral Solid/Tablet blank Within Guidelines
02257149 SENSIPAR - 60 MG/TABLET cinacalcet hydrochloride H05BX Oral Solid/Tablet blank Does Not Trigger
02257157 SENSIPAR - 90 MG/TABLET cinacalcet hydrochloride H05BX Oral Solid/Tablet blank Does Not Trigger
02308487 VECTIBIX - 20 MG/ML panitumumab L01XC Parenteral/Solution blank Within Guidelines
02308509 VECTIBIX - 20 MG/ML panitumumab L01XC Parenteral/Solution blank Within Guidelines
02368153 XGEVA - 120 MG/VIAL denosumab M05BX Parenteral/Solution blank Within Guidelines
Amicus Therapeutics UK Ltd
Amicus Therapeutics UK Ltd
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02468042 GALAFOLD - 123 MG/CAPSULE migalastat hydrochloride A16AX Oral Solid/Capsule blank Subj. Investigation
Aralez Pharmaceuticals Inc.
Aralez Pharmaceuticals Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02454130 BLEXTEN - 20 MG/TABLET bilastine R06AX Oral Solid/Tablet blank Subj. Investigation
02381680 CAMBIA - 50 MG/SACHET diclofenac potassium M01AB Oral Liquid/Powder for solution blank Within Guidelines
02373017 DURELA - 100 MG/CAPSULE tramadol hydrochloride N02AX Oral Solid/Modified release capsule blank Within Guidelines
02373025 DURELA - 200 MG/CAPSULE tramadol hydrochloride N02AX Oral Solid/Modified release capsule blank Within Guidelines
02373033 DURELA - 300 MG/CAPSULE tramadol hydrochloride N02AX Oral Solid/Modified release capsule blank Within Guidelines
02496305 SUVEXX 85/500 MG/TABLET sumatriptan/naproxen sodium N02CC Oral Solid/Tablet blank Within Guidelines
Astellas Pharma Canada Inc.
Astellas Pharma Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02402874 MYRBETRIQ - 25 MG/TABLET mirabegron G04BD Oral Solid/Modified release tablet blank Within Guidelines
02402882 MYRBETRIQ - 50 MG/TABLET mirabegron G04BD Oral Solid/Modified release tablet blank Within Guidelines
02495058 XOSPATA - 40 MG/TABLET gilteritinib L01XE Oral Solid/Tablet blank Subj. Investigation
02407329 XTANDI - 40 MG/CAPSULE enzalutamide L02BB Oral Solid/Capsule blank Within Guidelines
AstraZeneca Canada Inc.
AstraZeneca Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02455005 BRILINTA - 60 MG/TABLET ticagrelor B01AC Oral Solid/Tablet blank Within Guidelines
02368544 BRILINTA - 90 MG/TABLET ticagrelor B01AC Oral Solid/Tablet blank Within Guidelines
02448610 BYDUREON - 2 MG/DOSE exenatide A10BX Parenteral/Modified release injection blank Does Not Trigger
02361809 BYETTA - 5 MCG/DOSE exenatide A10BX Parenteral/Solution Expired Does Not Trigger
02361817 BYETTA - 10 MCG/DOSE exenatide A10BX Parenteral/Solution Expired Does Not Trigger
02491788 CALQUENCE - 100 MG/CAPSULE acalabrutinib L01XE Oral Solid/Capsule blank Within Guidelines
02439530 DUAKLIR GENUAIR 400/12 MCG/DOSE aclidinium bromide/formoterol fumarate dihydrate R03AL Pulmonary/Powder blank Within Guidelines
02514400 ENHERTU - 100 MG/VIAL trastuzumab deruxtecan L01XC Parenteral/Powder for solution Introduced Under Review
02473232 FASENRA - 30 MG/DOSE benralizumab R03DX Parenteral/Solution blank Within Guidelines
02496135 FASENRA PEN - 30 MG/DOSE benralizumab R03DX Parenteral/Solution Introduced Within Guidelines
02248624 FASLODEX - 250 MG/SYRINGE fulvestrant L02BA Parenteral/Solution Expired Subj. Investigation
02426544 FLUMIST QUADRIVALENT - 0.2 UNIT/DOSE influenza vaccine (live, attenuated) J07BB Nasal/Spray Expired Subj. Investigation
02435462 FORXIGA - 5 MG/TABLET dapagliflozin propanediol monohydrate A10BX Oral Solid/Tablet blank Within Guidelines
02435470 FORXIGA - 10 MG/TABLET dapagliflozin propanediol monohydrate A10BX Oral Solid/Tablet blank Within Guidelines
02468816 IMFINZI - 50 MG/ML durvalumab L01FF  Parenteral/Solution blank Within Guidelines
02389169 KOMBOGLYZE 500/2.5 MG/TABLET saxagliptin/metformin A10BD Oral Solid/Tablet Expired Within Guidelines
02389177 KOMBOGLYZE 850/2.5 MG/TABLET saxagliptin/metformin A10BD Oral Solid/Tablet Expired Within Guidelines
02389185 KOMBOGLYZE 1000/2.5 MG/TABLET saxagliptin/metformin A10BD Oral Solid/Tablet Expired Within Guidelines
02490714 LOKELMA - 5 G/SACHET sodium zirconium cyclosilicate V03AE  Parenteral/Powder for suspension blank Within Guidelines
02490722 LOKELMA - 10 G/SACHET sodium zirconium cyclosilicate V03AE  Parenteral/Powder for suspension blank Within Guidelines
02454408 LYNPARZA - 50 MG/CAPSULE olaparib L01XX Oral Solid/Capsule blank Within Guidelines
02475200 LYNPARZA - 100 MG/TABLET olaparib L01XX Oral Solid/Tablet blank Within Guidelines
02475219 LYNPARZA - 150 MG/TABLET olaparib L01XX Oral Solid/Tablet blank Within Guidelines
02375842 ONGLYZA - 2.5 MG/TABLET saxagliptin A10BH Oral Solid/Tablet Expired Within Guidelines
02333554 ONGLYZA - 5 MG/TABLET saxagliptin A10BH Oral Solid/Tablet Expired Within Guidelines
02456214 TAGRISSO - 40 MG/TABLET osimertinib L01EB Oral Solid/Tablet blank Within Guidelines
02456222 TAGRISSO - 80 MG/TABLET osimertinib L01EB   Oral Solid/Tablet blank Within Guidelines
02409720 TUDORZA GENUAIR - 400 MCG/DOSE aclidinium bromide R03BB Pulmonary/Powder blank Within Guidelines
02361701 VIMOVO 20/375 MG/TABLET naproxen/esomeprazole magnesium trihydrate M01AE Oral Solid/Modified release tablet blank Within Guidelines
02361728 VIMOVO 20/500 MG/TABLET naproxen/esomeprazole magnesium trihydrate M01AE Oral Solid/Modified release tablet blank Within Guidelines
02449935 XIGDUO 5/850 MG/TABLET dapagliflozin/metformin hydrochloride A10BD Oral Solid/Tablet blank Within Guidelines
02449943 XIGDUO 5/1000 MG/TABLET dapagliflozin/metformin hydrochloride A10BD Oral Solid/Tablet blank Within Guidelines
Avir Pharma Inc.
Avir Pharma Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02483971 CRESEMBA - 100 MG/CAPSULE isavuconazole J02AC Oral Solid/Capsule blank Within Guidelines
02483998 CRESEMBA - 200 MG/VIAL isavuconazole J02AC Parenteral/Powder for solution blank Within Guidelines
02513854 JORVEZA - 0.5 MG/TABLET budesonide A07EA Oral Solid/Tablet (oral disintegrating) Introduced Under Review
02493675 JORVEZA - 1 MG/TABLET budesonide A07EA Oral Solid/Tablet (oral disintegrating) Introduced Subj. Investigation
02446685 ZEVTERA - 500 MG/VIAL ceftobiprole medocaril sodium J01DI Parenteral/Powder for solution blank Within Guidelines

B

Bausch Health Canada Inc.
Bausch Health Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02281074 ACZONE - 50 MG/G dapsone D10AX Topical/Gel blank Does Not Trigger
02336847 BESIVANCE - 6 MG/ML besifloxacin S01AX Ophthalmic/Suspension blank Within Guidelines
02359685 BIACNA 1.2/0.025 clindamycin phosphate/tretinoin D10AF Topical/Gel Expired Within Guidelines
02472945 CONTRAVE 8/90 MG/TABLET naltrexone hcl/bupropion hcl A08AA Oral Solid/Tablet blank Within Guidelines
02499967 DUOBRII 0.1/0.45 MG/ML halobetasol propionate/tazarotene D05AX Topical/Lotion blank Subj. Investigation
02381389 EDARBI - 40 MG/TABLET azilsartan medoxomil C09CA Oral Solid/Tablet blank Within Guidelines
02381397 EDARBI - 80 MG/TABLET azilsartan medoxomil C09CA Oral Solid/Tablet blank Does Not Trigger
02397749 EDARBYCLOR 40/12.5 MG/TABLET azilsartan medoxomil/chlorthalidone C09DA Oral Solid/Tablet blank Subj. Investigation
02397765 EDARBYCLOR 40/25 MG/TABLET azilsartan medoxomil/chlorthalidone C09DA Oral Solid/Tablet blank Does Not Trigger
02268493 GLUMETZA - 500 MG/TABLET metformin hydrochloride A10BA Oral Solid/Modified release tablet blank Within Guidelines
02300451 GLUMETZA - 1000 MG/TABLET metformin hydrochloride A10BA Oral Solid/Modified release tablet blank Within Guidelines
02413388 JUBLIA - 100 MG/G efinaconazole D01AC Topical/Liquid blank Within Guidelines
02432463 LODALIS - 3.75 G/DOSE colesevelam hydrochloride C10AC Parenteral/Powder for solution blank Does Not Trigger
02373955 LODALIS - 625 MG/TABLET colesevelam hydrochloride C10AC Oral Solid/Tablet blank Within Guidelines
02125226 NIDAGEL - 7.5 MG/G metronidazole G01AF Vaginal/Gel Expired Within Guidelines
02439123 PROLENSA - 0.7 MG/ML bromfenac S01BC Ophthalmic/Drops blank Within Guidelines
02299194 RALIVIA - 100 MG/TABLET tramadol hydrochloride N02AX Oral Solid/Modified release tablet blank Within Guidelines
02299208 RALIVIA - 200 MG/TABLET tramadol hydrochloride N02AX Oral Solid/Modified release tablet blank Does Not Trigger
02299216 RALIVIA - 300 MG/TABLET tramadol hydrochloride N02AX Oral Solid/Modified release tablet blank Does Not Trigger
02473623 SILIQ - 210 MG/SYRINGE brodalumab L04AC Parenteral/Solution blank Within Guidelines
02365561 VYLOMA - 37.5 MG/G imiquimod D06BB Topical/Cream blank Within Guidelines
02484218 VYZULTA - 0.24 MG/ML latanoprostene bunod S01EE Ophthalmic/Solution blank Within Guidelines
02275090 WELLBUTRIN XL - 150 MG/TABLET bupropion hydrochloride N07BA Oral Solid/Modified release tablet blank Subj. Investigation
02275104 WELLBUTRIN XL - 300 MG/TABLET bupropion hydrochloride N07BA Oral Solid/Modified release tablet blank Within Guidelines
02340445 ZYCLARA - 250 MG/POUCH imiquimod D06BB Topical/Cream blank Within Guidelines
Baxter Corporation
Baxter Corporation
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02188880 BREVIBLOC - 10 MG/ML esmolol hydrochloride C07AB Parenteral/Solution blank Does Not Trigger
02309238 BREVIBLOC - 10 MG/ML esmolol hydrochloride C07AB Parenteral/Solution blank Does Not Trigger
Bayer Inc.
Bayer Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02412764 ADEMPAS - 0.5 MG/TABLET riociguat C02KX Oral Solid/Tablet blank Within Guidelines
02412772 ADEMPAS - 1 MG/TABLET riociguat C02KX Oral Solid/Tablet blank Within Guidelines
02412799 ADEMPAS - 1.5 MG/TABLET riociguat C02KX Oral Solid/Tablet blank Within Guidelines
02412802 ADEMPAS - 2 MG/TABLET riociguat C02KX Oral Solid/Tablet blank Within Guidelines
02412810 ADEMPAS - 2.5 MG/TABLET riociguat C02KX Oral Solid/Tablet blank Within Guidelines
02268825 ANGELIQ 1/1 MG/TABLET drospirenone/estradiol 17β G03FA Oral Solid/Tablet blank Within Guidelines
02505355 EYLEA - 40 MG/ML aflibercept S01LA Otic/Solution blank Within Guidelines
02415992 EYLEA - 40 MG/ML aflibercept S01LA Pulmonary/Solution blank Within Guidelines
02241089 GADOVIST 1.0 - 604.72 MG/ML gadobutrol V08CA Parenteral/Solution Expired Within Guidelines
02481790 JIVI antihemophilic factor (recombinant, b-domain deleted, pegylated) B02BD Parenteral/Powder for solution blank Does Not Trigger
02481782 JIVI antihemophilic factor (recombinant, b-domain deleted, pegylated) B02BD Parenteral/Powder for solution blank Within Guidelines
02481774 JIVI antihemophilic factor (recombinant, b-domain deleted, pegylated) B02BD Parenteral/Powder for solution blank Does Not Trigger
02481766 JIVI antihemophilic factor (recombinant, b-domain deleted, pegylated) B02BD Parenteral/Powder for solution blank Within Guidelines
02451441 KOVALTRY antihemophilic factor (recombinant) B02BD Parenteral/Powder for solution Expired Within Guidelines
02451468 KOVALTRY antihemophilic factor (recombinant) B02BD Parenteral/Powder for solution Expired Within Guidelines
02451476 KOVALTRY antihemophilic factor (recombinant) B02BD Parenteral/Powder for solution Expired Within Guidelines
02451484 KOVALTRY antihemophilic factor (recombinant) B02BD Parenteral/Powder for solution Expired Within Guidelines
02451492 KOVALTRY antihemophilic factor (recombinant) B02BD Parenteral/Powder for solution Expired Within Guidelines
02250470 LEVITRA - 10 MG/TABLET vardenafil hydrochloride G04BE Oral Solid/Tablet blank Does Not Trigger
02250489 LEVITRA - 20 MG/TABLET vardenafil hydrochloride G04BE Oral Solid/Tablet blank Subj. Investigation
02284227 NEXAVAR - 200 MG/TABLET sofarenib tosylate L01XE Oral Solid/Tablet blank Within Guidelines
02496348 NUBEQA - 300 MG/TABLET darolutamide L02BB Oral Solid/Tablet blank Subj. Investigation
02266121 SATIVEX 27/25 MG/ML delta-9-tetrahydrocannabinol/cannabidiol N02BG Dental - Sublingual buccal/Spray - buccal blank Subj. Investigation
02372436 STAXYN - 10 MG/TABLET vardenafil hydrochloride G04BE Oral Solid/Tablet blank Within Guidelines
02403390 STIVARGA - 40 MG/TABLET regorafenib L01XE Oral Solid/Tablet blank Within Guidelines
VERQUVO - 2.5 MG/TABLET vericiguat C01DX Oral Solid/Tablet Introduced Under Review
VERQUVO - 5 MG/TABLET vericiguat C01DX Oral Solid/Tablet Introduced Under Review
VERQUVO - 10 MG/TABLET vericiguat C01DX Oral Solid/Tablet Introduced Under Review
02490331 VITRAKVI - 20 MG/ML larotrectinib L01XE Oral Liquid/Solution blank Within Guidelines
02490315 VITRAKVI - 25 MG/CAPSULE larotrectinib L01XE Oral Solid/Capsule blank Within Guidelines
02490323 VITRAKVI - 100 MG/CAPSULE larotrectinib L01XE Oral Solid/Capsule blank Within Guidelines
02480808 XARELTO - 2.5 MG/TABLET rivaroxaban B01AF Oral Solid/Tablet blank Within Guidelines
02316986 XARELTO - 10 MG/TABLET rivaroxaban B01AF Oral Solid/Tablet blank Within Guidelines
02378604 XARELTO - 15 MG/TABLET rivaroxaban B01AF Oral Solid/Tablet blank Within Guidelines
02378612 XARELTO - 20 MG/TABLET rivaroxaban B01AF Oral Solid/Tablet blank Within Guidelines
02510170 XARELTO - 1 MG/ML rivaroxaban B01AF Oral Liquid/Granules for suspension Introduced Under Review
02510162 XARELTO - 1 MG/ML rivaroxaban B01AF Oral Liquid/Granules for suspension Introduced Under Review
02418398 XOFIGO - 1000 KBQ/ML radium ra 223 dichloride V10XX Parenteral/Solution blank Within Guidelines
02261723 YASMIN 21 3/0.03 drospirenone/ethinyl estradiol G03AA Oral Solid/Tablet blank Subj. Investigation
02261731 YASMIN 28 3/0.03 drospirenone/ethinyl estradiol G03AA Oral Solid/Tablet blank Within Guidelines
02321157 YAZ 28 3/0.02 drospirenone/ethinyl estradiol G03AA Oral Solid/Tablet blank Within Guidelines
02387433 YAZ PLUS drospirenone/ethinyl estradiol/levomefolate calcium/levomefolate calcium G03AA Oral Solid/Tablet blank Within Guidelines
BeiGene Ltd
BeiGene Ltd
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02512963 BRUKINSA - 80 MG/CAPSULE zanubrutinib L01EL Oral Solid/Capsule Introduced Within Guidelines
BGP Pharma ULC
BGP Pharma ULC
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02249499 ANDROGEL 1% - 1.25 G/DOSE testosterone G03BA Topical/Gel blank Within Guidelines
02245345 ANDROGEL 1% - 2.5 G/POUCH testosterone G03BA Topical/Gel blank Within Guidelines
02245346 ANDROGEL 1% - 5 G/POUCH testosterone G03BA Topical/Gel blank Within Guidelines
02146908 BIAXIN - 25 MG/ML clarithromycin J01FA Oral Liquid/Powder for suspension blank Within Guidelines
02244641 BIAXIN - 50 MG/ML clarithromycin J01FA Oral Liquid/Powder for suspension blank Within Guidelines
01984853 BIAXIN - 250 MG/TABLET clarithromycin J01FA Oral Solid/Tablet blank Subj. Investigation
02126710 BIAXIN - 500 MG/TABLET clarithromycin J01FA Oral Solid/Tablet blank Does Not Trigger
02200104 CREON MINIMICROSPHERES 10 - 10000 UNIT/CAPSULE pancreatin A09AA Oral Solid/Capsule blank Within Guidelines
01985205 CREON MINIMICROSPHERES 25 - 25000 UNIT/CAPSULE pancreatin A09AA Oral Solid/Capsule blank Within Guidelines
02494639 CREON MINIMICROSPHERES 35 - 35000 UNIT/CAPSULE pancreatin A09AA Oral Solid/Capsule Introduced Does Not Trigger
02445158 CREON MINIMICROSPHERES MICRO - 5000 UNIT/DOSE pancreatin A09AA Oral Solid/Granule blank Within Guidelines
02432889 DYMISTA 137/50 MCG/DOSE azelastine hydrochloride/fluticasone propionate R01AD Nasal/Solution blank Within Guidelines
02269074 LIPIDIL EZ - 48 MG/TABLET fenofibrate C10AB Oral Solid/Tablet blank Within Guidelines
02269082 LIPIDIL EZ - 145 MG/TABLET fenofibrate C10AB Oral Solid/Tablet blank Subj. Investigation
02241602 LIPIDIL SUPRA - 160 MG/TABLET fenofibrate C10AB Oral Solid/Tablet blank Within Guidelines
02365154 TOBI PODHALER - 28 MG/CAPSULE tobramycin J01GB Pulmonary/Powder blank Within Guidelines
Biogen Canada Inc.
Biogen Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02269201 AVONEX PS - 30 MCG/SYRINGE interferon beta-1a L03AB Parenteral/Solution blank Within Guidelines
02379910 FAMPYRA - 10 MG/TABLET fampridine N07XX Oral Solid/Modified release tablet blank Does Not Trigger
02444402 PLEGRIDY peginterferon beta-1a L03AB Parenteral/Solution blank Within Guidelines
02444399 PLEGRIDY - 125 MCG/SYRINGE peginterferon beta-1a L03AB Parenteral/Solution blank Does Not Trigger
02465663 SPINRAZA - 2.4 MG/ML nusinersen sodium M09AX Parenteral/Solution blank Within Guidelines
02404508 TECFIDERA - 120 MG/CAPSULE dimethyl fumarate L04AX Oral Solid/Capsule blank Within Guidelines
02420201 TECFIDERA - 240 MG/CAPSULE dimethyl fumarate L04AX Oral Solid/Capsule blank Within Guidelines
02286386 TYSABRI - 20 MG/ML natalizumab L04AA Parenteral/Powder for solution blank Subj. Investigation
BioMarin Pharmaceutical Canada Inc.
BioMarin Pharmaceutical Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02484013 BRINEURA - 300 MG/PACK cerliponase alfa A16AB Parenteral/Solution blank Within Guidelines
02350580 KUVAN - 100 MG/TABLET sapropterin dihydrochloride A16AX Oral Solid/Tablet blank Within Guidelines
02482207 KUVAN - 100 MG/SACHET sapropterin dihydrochloride A16AX Oral Liquid/Powder for solution blank Within Guidelines
02482215 KUVAN - 500 MG/SACHET sapropterin dihydrochloride A16AX Oral Liquid/Powder for solution blank Within Guidelines
02412683 NAGLAZYME - 1 MG/ML galsulfase A16AB Parenteral/Solution blank Within Guidelines
02427184 VIMIZIM - 1 MG/ML elosulfase alfa A16AB Parenteral/Solution Introduced Under Review
Boehringer Ingelheim (Canada) Ltd
Boehringer Ingelheim (Canada) Ltd
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02419106 COMBIVENT RESPIMAT 20/100 MCG/ACTUATION ipratropium bromide monohydrate/salbutamol sulfate R03AL Pulmonary/Solution blank Subj. Investigation
02415666 GIOTRIF - 20 MG/TABLET afatinib L01XE Oral Solid/Tablet blank Subj. Investigation
02415674 GIOTRIF - 30 MG/TABLET afatinib L01XE Oral Solid/Tablet blank Subj. Investigation
02415682 GIOTRIF - 40 MG/TABLET afatinib L01XE Oral Solid/Tablet blank Subj. Investigation
02459752 GLYXAMBI 10/5 MG/TABLET empagliflozin/linagliptin A10BD Oral Solid/Tablet blank Within Guidelines
02459760 GLYXAMBI 25/5 MG/TABLET empagliflozin/linagliptin A10BD Oral Solid/Tablet blank Within Guidelines
02441888 INSPIOLTO RESPIMAT 2.5/2.5 MCG/ACTUATION tiotropium bromide monohydrate/olodaterol hydrochloride R03BB Pulmonary/Solution blank Within Guidelines
02443937 JARDIANCE - 10 MG/TABLET empagliflozin A10BX Oral Solid/Tablet blank Within Guidelines
02443945 JARDIANCE - 25 MG/TABLET empagliflozin A10BX Oral Solid/Tablet blank Subj. Investigation
02403250 JENTADUETO 2.5/500 MG/TABLET linagliptin/metforim  A10BD Oral Solid/Tablet blank Within Guidelines
02403269 JENTADUETO 2.5/850 MG/TABLET linagliptin/metforim  A10BD Oral Solid/Tablet blank Within Guidelines
02403277 JENTADUETO 2.5/1000 MG/TABLET linagliptin/metforim  A10BD Oral Solid/Tablet blank Within Guidelines
02443066 OFEV - 100 MG/CAPSULE nintedanib L01XE Oral Solid/Capsule blank Subj. Investigation
02443074 OFEV - 150 MG/CAPSULE nintedanib L01XE Oral Solid/Capsule blank Subj. Investigation
02312433 PRADAXA - 75 MG/CAPSULE dabigatran etexilate B01AE Oral Solid/Capsule blank Within Guidelines
02312441 PRADAXA - 110 MG/CAPSULE dabigatran etexilate B01AE Oral Solid/Capsule blank Within Guidelines
02358808 PRADAXA - 150 MG/CAPSULE dabigatran etexilate B01AE Oral Solid/Capsule blank Within Guidelines
02456575 SYNJARDY 5/500 MG/TABLET empagliflozin/metformin hydrochloride A10BD Oral Solid/Tablet blank Within Guidelines
02456583 SYNJARDY 5/850 MG/TABLET empagliflozin/metformin hydrochloride A10BD Oral Solid/Tablet blank Subj. Investigation
02456591 SYNJARDY 5/1000 MG/TABLET empagliflozin/metformin hydrochloride A10BD Oral Solid/Tablet blank Within Guidelines
02456605 SYNJARDY 12.5/500 MG/TABLET empagliflozin/metformin hydrochloride A10BD Oral Solid/Tablet blank Does Not Trigger
02456613 SYNJARDY 12.5/850 MG/TABLET empagliflozin/metformin hydrochloride A10BD Oral Solid/Tablet blank Subj. Investigation
02456621 SYNJARDY 12.5/1000 MG/TABLET empagliflozin/metformin hydrochloride A10BD Oral Solid/Tablet blank Subj. Investigation
02370921 TRAJENTA - 5 MG/TABLET linagliptin A10BH Oral Solid/Tablet blank Within Guidelines
Bristol-Myers Squibb Canada Co.
Bristol-Myers Squibb Canada Co.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02282224 BARACLUDE - 0.5 MG/TABLET entecavir J05AF Oral Solid/Tablet blank Within Guidelines
02377233 ELIQUIS - 2.5 MG/TABLET apixaban B01AF Oral Solid/Tablet blank Within Guidelines
02397714 ELIQUIS - 5 MG/TABLET apixaban B01AF Oral Solid/Tablet blank Within Guidelines
02446626 OPDIVO - 40 MG/VIAL nivolumab L01XC Parenteral/Solution blank Within Guidelines
02446634 OPDIVO - 100 MG/VIAL nivolumab L01XC Parenteral/Solution blank Within Guidelines
02402475 ORENCIA - 125 MG/SYRINGE abatacept L04AA Parenteral/Solution blank Within Guidelines
02282097 ORENCIA - 250 MG/VIAL abatacept L04AA Parenteral/Powder for solution blank Within Guidelines
02293129 SPRYCEL - 20 MG/TABLET dasatinib L01XE Oral Solid/Tablet blank Within Guidelines
02293137 SPRYCEL - 50 MG/TABLET dasatinib L01XE Oral Solid/Tablet blank Within Guidelines
02293145 SPRYCEL - 70 MG/TABLET dasatinib L01XE Oral Solid/Tablet blank Within Guidelines
02360810 SPRYCEL - 80 MG/TABLET dasatinib L01XE Oral Solid/Tablet blank Within Guidelines
02320193 SPRYCEL - 100 MG/TABLET dasatinib L01XE Oral Solid/Tablet blank Within Guidelines
02360829 SPRYCEL - 140 MG/TABLET dasatinib L01XE Oral Solid/Tablet blank Within Guidelines
02379384 YERVOY - 5 MG/ML ipilimumab L01XC Parenteral/Solution blank Within Guidelines

C

Celgene Inc.
Celgene Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02281066 ABRAXANE - 100 MG/VIAL nanoparticle albumin-bound paclitaxel L01CD Parenteral/Suspension or Emulsion blank Within Guidelines
02510197 ONUREG - 200 MG/TABLET azacitidine L01BC Oral Solid/Tablet Introduced Under Review
02510200 ONUREG - 300 MG/TABLET azacitidine L01BC Oral Solid/Tablet Introduced Under Review
02419580 POMALYST - 1 MG/CAPSULE pomalidomide L04AX Oral Solid/Capsule blank Within Guidelines
02419599 POMALYST - 2 MG/CAPSULE pomalidomide L04AX Oral Solid/Capsule blank Within Guidelines
02419602 POMALYST - 3 MG/CAPSULE pomalidomide L04AX Oral Solid/Capsule blank Within Guidelines
02419610 POMALYST - 4 MG/CAPSULE pomalidomide L04AX Oral Solid/Capsule blank Within Guidelines
02505541 REBLOZYL - 25 MG/VIAL luspatercept B03XA Parenteral/Powder for solution blank Within Guidelines
02505568 REBLOZYL - 75 MG/VIAL luspatercept B03XA Parenteral/Powder for solution blank Within Guidelines
02459418 REVLIMID - 2.5 MG/CAPSULE lenalidomide L04AX Oral Solid/Capsule blank Subj. Investigation
02304899 REVLIMID - 5 MG/CAPSULE lenalidomide L04AX Oral Solid/Capsule blank Subj. Investigation
02304902 REVLIMID - 10 MG/CAPSULE lenalidomide L04AX Oral Solid/Capsule blank Within Guidelines
02317699 REVLIMID - 15 MG/CAPSULE lenalidomide L04AX Oral Solid/Capsule blank Does Not Trigger
02440601 REVLIMID - 20 MG/CAPSULE lenalidomide L04AX Oral Solid/Capsule blank Within Guidelines
02317710 REVLIMID - 25 MG/CAPSULE lenalidomide L04AX Oral Solid/Capsule blank Within Guidelines
02355191 THALOMID - 50 MG/CAPSULE thalidomide L04AX Oral Solid/Capsule blank VCU
02355205 THALOMID - 100 MG/CAPSULE thalidomide L04AX Oral Solid/Capsule blank VCU
02355221 THALOMID - 200 MG/CAPSULE thalidomide L04AX Oral Solid/Capsule blank VCU
02505991 ZEPOSIA - 0.92 MG/CAPSULE ozanimod L04AA Oral Solid/Capsule blank Within Guidelines
02506009 ZEPOSIA 0.23/0.46 ozanimod L04AA Oral Solid/Capsule blank Within Guidelines
Cheplapharm Arzneimittel GmbH
Cheplapharm Arzneimittel GmbH
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02240325 XENICAL - 120 MG/CAPSULE orlistat A08AB Oral Solid/Capsule blank Within Guidelines
Chiesi USA Inc.
Chiesi USA Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
CARDENE I.V. - 20 MG/DOSE nicardipine hydrochloride C08CA Parenteral/Solution blank Subj. Investigation
CARDENE I.V. - 20 MG/DOSE nicardipine hydrochloride C08CA Parenteral/Solution blank Subj. Investigation
CARDENE I.V. - 40 MG/DOSE nicardipine hydrochloride C08CA Parenteral/Solution blank Subj. Investigation
CARDENE I.V. - 40 MG/DOSE nicardipine hydrochloride C08CA Parenteral/Solution blank Subj. Investigation
02366223 CLEVIPREX - 0.5 MG/ML clevidipine C08CA Parenteral/Suspension or Emulsion blank Subj. Investigation
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02462400 BRINAVESS - 20 MG/ML vernakalant hydrochloride C01BG Parenteral/Solution blank Does Not Trigger
02463504 OZANEX - 10 MG/G ozenoxacin D06AX Topical/Cream blank Within Guidelines
CSL Behring Canada Inc.
CSL Behring Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02418738 CORIFACT 250 - 250 IU/ML factor xiii concentrate, human B02BD Parenteral/Powder for solution blank Subj. Investigation
02418746 CORIFACT 1250 - 1250 IU/ML factor xiii concentrate, human B02BD Parenteral/Powder for solution blank Subj. Investigation
02370352 HIZENTRA - 200 MG/ML subcutaneous immune globulin (human) J06BA Parenteral/Solution blank Subj. Investigation
02463059 HIZENTRA - 200 MG/ML subcutaneous immune globulin (human) J06BA Parenteral/Solution blank Subj. Investigation
02498251 HIZENTRA - 200 MG/ML subcutaneous immunoglobulin (human) J06BA Parenteral/Solution Introduced Within Guidelines
02463067 HIZENTRA - 200 MG/ML subcutaneous immune globulin (human) J06BA Parenteral/Solution blank Subj. Investigation
02451352 IDELVION - 1000 IU/VIAL coagulation factor ix (recombinant), albumin fusion protein (rix-fp) B02BD Parenteral/Powder for solution blank Subj. Investigation
02304619 PRIVIGEN - 100 MG/ML immuneglobulin (human) J06BA Parenteral/Solution blank Subj. Investigation

D

Duchesnay Inc.
Duchesnay Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
00609129 DICLECTIN 10/10 MG/TABLET doxylamine succinate/pyridoxine hydrochloride R06AA Oral Solid/Modified release tablet blank Within Guidelines
02460262 MICTORYL - 30 MG/CAPSULE propiverine hcl G04BD Oral Solid/Modified release capsule blank Within Guidelines
02460270 MICTORYL - 45 MG/CAPSULE propiverine hcl G04BD Oral Solid/Modified release capsule blank Within Guidelines
02460289 MICTORYL PEDIATRIC - 5 MG/TABLET propiverine hcl G04BD Oral Solid/Tablet blank Within Guidelines
02451573 PREGVIT multivitamins-minerals B03AE Oral Solid/Tablet blank Does Not Trigger
02451581 PREGVIT FOLIC 5 multivitamins-minerals B03AE Oral Solid/Tablet blank Within Guidelines
Dutch Ophthalmic Research Center (International) B.V.
Dutch Ophthalmic Research Center (International) B.V.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02510995 TISSUEBLUE - 0.25 MG/ML brilliant blue g  S01K Ophthalmic/Other Introduced Under Review

E

Eisai Ltd
Eisai Ltd
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02507366 DAYVIGO - 5 MG/TABLET lemborexant N05CM Oral Solid/Tablet blank VCU
02507374 DAYVIGO - 10 MG/TABLET lemborexant N05CM Oral Solid/Tablet blank VCU
02404516 FYCOMPA - 2 MG/TABLET perampanel N03AX Oral Solid/Tablet blank Within Guidelines
02404524 FYCOMPA - 4 MG/TABLET perampanel N03AX Oral Solid/Tablet blank Within Guidelines
02404532 FYCOMPA - 6 MG/TABLET perampanel N03AX Oral Solid/Tablet blank Within Guidelines
02404540 FYCOMPA - 8 MG/TABLET perampanel N03AX Oral Solid/Tablet blank Within Guidelines
02404559 FYCOMPA - 10 MG/TABLET perampanel N03AX Oral Solid/Tablet blank Within Guidelines
02404567 FYCOMPA - 12 MG/TABLET perampanel N03AX Oral Solid/Tablet blank Within Guidelines
02377438 HALAVEN - 1 MG/VIAL eribulin mesylate L01XX Parenteral/Solution blank Within Guidelines
02484056 LENVIMA - 4 MG/DAY lenvatinib mesylate L01XE Oral Solid/Capsule blank Within Guidelines
02468220 LENVIMA - 8 MG/DAY lenvatinib mesylate L01XE Oral Solid/Capsule blank Within Guidelines
02450321 LENVIMA - 10 MG/DAY lenvatinib mesylate L01XE Oral Solid/Capsule blank Within Guidelines
02484129 LENVIMA - 12 MG/DAY lenvatinib mesylate L01XE Oral Solid/Capsule blank Within Guidelines
02468239 LENVIMA - 18 MG/DAY lenvatinib mesylate L01XE Oral Solid/Capsule blank Within Guidelines
02450313 LENVIMA 10/4 MG/DAY lenvatinib mesylate L01XE Oral Solid/Capsule blank Within Guidelines
02450305 LENVIMA 10/10 MG/DAY lenvatinib mesylate L01XE Oral Solid/Capsule blank Within Guidelines
02450291 LENVIMA 10/10/4 MG/DAY lenvatinib mesylate L01XE Oral Solid/Capsule blank Within Guidelines
Eli Lilly Canada Inc.
Eli Lilly Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02338327 ADCIRCA - 20 MG/TABLET tadalafil G04BE Oral Solid/Tablet blank Within Guidelines
02296888 CIALIS - 2.5 MG/TABLET tadalafil G04BE Oral Solid/Tablet blank Does Not Trigger
02296896 CIALIS - 5 MG/TABLET tadalafil G04BE Oral Solid/Tablet blank Subj. Investigation
02248088 CIALIS - 10 MG/TABLET tadalafil G04BE Oral Solid/Tablet blank Within Guidelines
02248089 CIALIS - 20 MG/TABLET tadalafil G04BE Oral Solid/Tablet blank Within Guidelines
02443805 CYRAMZA - 10 MG/ML ramucirumab L01XC Parenteral/Solution blank Within Guidelines
02505134 EMGALITY - 100 MG/ML galcanezumab N02CD Parenteral/Solution Introduced Under Review
02491087 EMGALITY - 120 MG/ML galcanezumab N02CD Parenteral/Solution blank Subj. Investigation
02491060 EMGALITY - 120 MG/ML galcanezumab N02CD Parenteral/Solution blank Subj. Investigation
02469227 LARTRUVO - 500 MG/VIAL olaratumab L01XC Parenteral/Solution blank Within Guidelines
02480018 OLUMIANT - 2 MG/TABLET baricitinib L04AA Oral Solid/Tablet blank Within Guidelines
02455102 TALTZ - 80 MG/ML ixekizumab L04AC Parenteral/Solution blank Within Guidelines
02455110 TALTZ - 80 MG/ML ixekizumab L04AC Parenteral/Solution blank Does Not Trigger
02448599 TRULICITY - 0.75 MG/PEN dulaglutide A10BX Parenteral/Solution blank Within Guidelines
02448602 TRULICITY - 1.5 MG/PEN dulaglutide A10BX Parenteral/Solution blank Within Guidelines
02487098 VERZENIO - 50 MG/TABLET abemaciclib L01XE Oral Solid/Tablet blank Does Not Trigger
02487101 VERZENIO - 100 MG/TABLET abemaciclib L01XE Oral Solid/Tablet blank Within Guidelines
02487128 VERZENIO - 150 MG/TABLET abemaciclib L01XE Oral Solid/Tablet blank Does Not Trigger
02487136 VERZENIO - 200 MG/TABLET abemaciclib L01XE Oral Solid/Tablet blank Within Guidelines
Elvium Life Sciences
Elvium Life Sciences
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02468735 AKYNZEO 300/0.5 MG/CAPSULE netupitant/palonosetron A04AA Oral Solid/Capsule blank Within Guidelines
02381729 ALOXI - 0.5 MG/CAPSULE palonosetron hydrochloride A04AA Oral Solid/Capsule blank Does Not Trigger
02381710 ALOXI - 0.05 MG/ML palonosetron hydrochloride A04AA Parenteral/Solution blank Does Not Trigger
02470292 FOQUEST - 25 MG/CAPSULE methylphenidate hydrochloride N06BA Oral Solid/Capsule blank Does Not Trigger
02470306 FOQUEST - 35 MG/CAPSULE methylphenidate hydrochloride N06BA Oral Solid/Capsule blank Does Not Trigger
02470314 FOQUEST - 45 MG/CAPSULE methylphenidate hydrochloride N06BA Oral Solid/Capsule blank Does Not Trigger
02470322 FOQUEST - 55 MG/CAPSULE methylphenidate hydrochloride N06BA Oral Solid/Capsule blank Does Not Trigger
02470330 FOQUEST - 70 MG/CAPSULE methylphenidate hydrochloride N06BA Oral Solid/Capsule blank Does Not Trigger
02470349 FOQUEST - 85 MG/CAPSULE methylphenidate hydrochloride N06BA Oral Solid/Capsule blank Within Guidelines
02470357 FOQUEST - 100 MG/CAPSULE methylphenidate hydrochloride N06BA Oral Solid/Capsule blank Does Not Trigger
EMD Serono Canada Inc.
EMD Serono Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02469723 BAVENCIO - 20 MG/ML avelumab L01XC Parenteral/Solution blank Within Guidelines
02470179 MAVENCLAD - 10 MG/TABLET cladribine L01BB Oral Solid/Tablet blank Within Guidelines
02269066 LUVERIS - 75 UNIT/VIAL lutropin alpha G03GA Parenteral/Powder for solution blank Subj. Investigation
02516322 TEPMETKO - 225 MG/TABLET tepotinib L01EX Oral Solid/Tablet Introduced Under Review
EUSA Pharma
EUSA Pharma
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02435128 SYLVANT - 100 MG/VIAL siltuximab L04AC Parenteral/Powder for solution blank Within Guidelines
02435136 SYLVANT - 400 MG/VIAL siltuximab L04AC Parenteral/Powder for solution blank Within Guidelines

F

Ferring Pharmaceuticals Inc.
Ferring Pharmaceuticals Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
00824305 DDAVP - 0.1 MG/TABLET desmopressin acetate H01BA Oral Solid/Tablet blank Within Guidelines
00824143 DDAVP - 0.2 MG/TABLET desmopressin acetate H01BA Oral Solid/Tablet blank Within Guidelines
02284995 DDAVP MELT - 60 MCG/TABLET desmopressin acetate H01BA Oral Solid/Tablet blank Does Not Trigger
02285002 DDAVP MELT - 120 MCG/TABLET desmopressin acetate H01BA Oral Solid/Tablet blank Within Guidelines
02285010 DDAVP MELT - 240 MCG/TABLET desmopressin acetate H01BA Oral Solid/Tablet blank Does Not Trigger
02397927 NOCDURNA - 25 MCG/TABLET desmopressin acetate H01BA Dental - Sublingual buccal/Sublingual tablet blank Within Guidelines
02431076 NOCDURNA - 50 MCG/TABLET desmopressin acetate H01BA Dental - Sublingual buccal/Sublingual tablet blank Within Guidelines
02399466 PENTASA - 1 GM/TABLET mesalazine A07EC Oral Solid/Tablet Expired Within Guidelines
02099683 PENTASA - 500 MG/TABLET mesalazine A07EC Oral Solid/Tablet Expired Within Guidelines
Fresenius Kabi
Fresenius Kabi
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
OMEGAVEN - 0.1 G/ML fish oil triglycerides blank Parenteral/Suspension or Emulsion blank Under Review
OMEGAVEN - 0.1 G/ML fish oil triglycerides blank Parenteral/Suspension or Emulsion blank Under Review

G

Galderma Canada Inc.
Galderma Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02494175 AKLIEF - 50 MCG/G trifarotene D10AD Topical/Cream blank Within Guidelines
02375885 APPRILON - 40 MG/CAPSULE doxycycline monohydrate J01AA Oral Solid/Modified release capsule blank Does Not Trigger
02421208 ONRELTEA - 5 MG/G brimonidine tartrate S01EA Topical/Gel blank Within Guidelines
02440342 ROSIVER - 10 MG/G ivermectin D11AX Topical/Cream blank Within Guidelines
02365871  TACTUPUMP 1/25 MG/G adapalene/benzoyl peroxide D10AD Topical/Gel Expired NOH
02446235 TACTUPUMP FORTE - 70 G/PUMP adapalene/benzoyl peroxide D10AD Topical/Gel Expired NOH
GE Healthcare Inc.
GE Healthcare Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02470624 DATSCAN - 74 MBQ/ML ioflupane (123i) V09AB Parenteral/Solution blank Subj. Investigation
Gilead Sciences Canada Inc.
Gilead Sciences Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02300699 ATRIPLA 600/200/300 MG/TABLET efavirenz/emtricitabine/tenofovir disoproxil fumarate J05AR Oral Solid/Tablet blank Within Guidelines
02478579 BIKTARVY 25/50/200 MG/TABLET bictegravir/emtricitabine/tenofovir alafenamide J05AR Oral Solid/Tablet blank Within Guidelines
02329840 CAYSTON - 75 MG/VIAL aztreonam for inhalation solution J01DF Pulmonary/Powder blank Within Guidelines
02374129 COMPLERA 200/300/25 MG/TABLET emtricitabine/rilpivirine/tenofovir df J05AR Oral Solid/Tablet blank Within Guidelines
02454416 DESCOVY 200/10 MG/TABLET emtricitabine/tenofovir alafenamide J05AR Oral Solid/Tablet blank Subj. Investigation
02454424 DESCOVY 200/25 MG/TABLET emtricitabine/tenofovir alafenamide J05AR Oral Solid/Tablet blank Subj. Investigation
02456370 EPCLUSA 400/100 MG/TABLET sofosbuvir/velpatasvir J05AX Oral Solid/Tablet blank Within Guidelines
02449498 GENVOYA 200/150/150/10 MG/TABLET elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide J05AR Oral Solid/Tablet blank Within Guidelines
02432226 HARVONI 90/400 MG/TABLET ledipasvir/sofosbuvir J05AX Oral Solid/Tablet blank Within Guidelines
02247823 HEPSERA - 10 MG/TABLET adefovir dipivoxil J05AF Oral Solid/Tablet Expired Subj. Investigation
02461463 ODEFSEY 200/25/25 MG/TABLET emtricitabine/rilpivirine/tenofovir alafenamide J05AR Oral Solid/Tablet blank Within Guidelines
02418355 SOVALDI - 400 MG/TABLET sofosbuvir J05AX Oral Solid/Tablet blank Within Guidelines
02397137 STRIBILD 150/150/200/300 MG/TABLET elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate J05AR Oral Solid/Tablet blank Within Guidelines
02520788 TRODELVY - 180 MG/VIAL sacituzumab govitecan L01XC Parenteral/Powder for solution Introduced Under Review
02274906 TRUVADA 200/300 MG/TABLET emtricitabine/tenofovir disoproxil fumarate J05AR Oral Solid/Tablet blank Subj. Investigation
02502143 VEKLURY - 100 MG/VIAL remdesivir J05AB   Parenteral/Powder for solution blank Under Review
02464241 VEMLIDY - 25 MG/TABLET tenofovir alafenamide J05AF Oral Solid/Tablet blank Within Guidelines
02247128 VIREAD - 300 MG/TABLET tenofovir disoproxil fumarate J05AF Oral Solid/Tablet Expired Within Guidelines
02467542 VOSEVI 400/100/100 MG/TABLET sofosbuvir/velpatasvir/voxilaprevir J05AX Oral Solid/Tablet blank Within Guidelines
02438798 ZYDELIG - 100 MG/TABLET idelalisib L01XX Oral Solid/Tablet blank Within Guidelines
02438801 ZYDELIG - 150 MG/TABLET idelalisib L01XX Oral Solid/Tablet blank Within Guidelines
GlaxoSmithKline Inc.
GlaxoSmithKline Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02418401 ANORO ELLIPTA 62.5/25 MCG/DOSE umeclidinium bromide/vilanterol trifenatate R03AL Pulmonary/Powder blank Within Guidelines
02446561 ARNUITY ELLIPTA - 100 MCG/DOSE fluticasone furoate R01AD Pulmonary/Powder Expired Within Guidelines
02446588 ARNUITY ELLIPTA  - 200 MCG/DOSE fluticasone furoate R01AD Pulmonary/Powder Expired Within Guidelines
02298589 AVAMYS - 27.5 MCG/DOSE fluticasone furoate R01AD Nasal/Spray Expired Within Guidelines
02370050 BENLYSTA - 120 MG/VIAL belimumab L04AA Parenteral/Powder for solution blank Within Guidelines
02370069 BENLYSTA - 400 MG/VIAL belimumab L04AA Parenteral/Powder for solution blank Within Guidelines
02470489 BENLYSTA - 200 MG/ML belimumab L04AA Parenteral/Solution blank Subj. Investigation
02417030 BEXSERO multicomponent meningococcal b vaccine J07AH Parenteral/Suspension or Emulsion blank Does Not Trigger
02247600 BOOSTRIX combined diphtheria, tetanus, acellular pertussis (adsorbed) vaccine J07AX Parenteral/Suspension or Emulsion blank Within Guidelines
02312557 BOOSTRIX POLIO combined diphtheria, tetanus, acellular pertussis (adsorbed) and inactivated poliomyelitis J07CA Parenteral/Suspension or Emulsion blank Does Not Trigger
02408872 BREO ELLIPTA 100/25 MCG/DOSE fluticasone furoate/vilanterol R03AK Pulmonary/Powder blank Within Guidelines
02444186 BREO ELLIPTA 200/25 MCG/DOSE fluticasone furoate/vilanterol R03AK Pulmonary/Powder blank Within Guidelines
02212307 CEFTIN - 25 MG/ML cefuroxime axetil J01DC Oral Liquid/Powder for suspension blank Subj. Investigation
02342227 CERVARIX human papillomavirus vaccine (recombinant) J07BM Parenteral/Suspension or Emulsion blank Subj. Investigation
02382822 CLINDOXYL ADV GEL 10/30 MG/G clindamycin/benzoyl peroxide D10AF Topical/Gel blank Within Guidelines
02243158 CLINDOXYL GEL 10/50 MG/G clindamycin/benzoyl peroxide D10AF Topical/Gel blank Subj. Investigation
01919431 ENGERIX-B hepatitis b vaccine (recombinant) J07BC Parenteral/Suspension or Emulsion blank Within Guidelines
02487039 ENGERIX-B hepatitis b vaccine (recombinant) J07BC Parenteral/Suspension or Emulsion blank Subj. Investigation
02296454 ENGERIX-B PEDIATRIC - 20 MCG/ML hepatitis b vaccine (recombinant) J07BC Parenteral/Suspension or Emulsion blank Subj. Investigation
02487020 ENGERIX-B PEDIATRIC - 20 MCG/ML hepatitis b vaccine (recombinant) J07BC Parenteral/Suspension or Emulsion blank Within Guidelines
02420783 FLULAVAL TETRA - 15 UNIT/DOSE quadrivalent influenza vaccine (inactivated, split-virion) J07BB Parenteral/Suspension or Emulsion blank Subj. Investigation
02420686 FLUVIRAL influenza virus vaccine trivalent (inactivated, split-virion) J07BB Parenteral/Suspension or Emulsion blank Subj. Investigation
02187078 HAVRIX 1440 - 1440 UNIT/ML hepatitis a vaccine, inactivated J07BC Parenteral/Suspension or Emulsion blank Subj. Investigation
02231056 HAVRIX 720 JUNIOR - 1440 UNIT/ML hepatitis a vaccine, inactivated J07BC Parenteral/Suspension or Emulsion blank Subj. Investigation
02239200 HIBERIX haemophilus influenzae type b (hib) conjugate vaccine (tetanus protein – conjugate) J07AG Parenteral/Powder for solution blank Does Not Trigger
02230418 IMITREX - 5 MG/DOSE sumatriptan hemisulphate N02CC Nasal/Spray blank Within Guidelines
02230420 IMITREX - 20 MG/DOSE sumatriptan hemisulphate N02CC Nasal/Spray blank Within Guidelines
02212188 IMITREX - 12 MG/ML sumatriptan succinate N02CC Parenteral/Solution blank Does Not Trigger
02212153 IMITREX DF - 50 MG/TABLET sumatriptan succinate N02CC Oral Solid/Tablet blank Within Guidelines
02212161 IMITREX DF - 100 MG/TABLET sumatriptan succinate N02CC Oral Solid/Tablet blank Within Guidelines
02423596 INCRUSE ELLIPTA - 62.5 MCG/DOSE umeclidinium bromide  R03BB Pulmonary/Powder blank Within Guidelines
02253852 INFANRIX HEXA combined diphtheria and tetanus toxoids, acellular pertussis, hepatitis b (recombinant), inactivated poliomyelitis and adsorbed conjugated haemophilus influenzae type b vaccine J07CA Parenteral/Suspension or Emulsion blank Within Guidelines
02241284 INFANRIX-IPV combined diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine J07CA Parenteral/Suspension or Emulsion blank Within Guidelines
02440709 MENJUGATE LIQUID meningococcal group c conjugate vaccine J07AH Parenteral/Suspension or Emulsion blank Within Guidelines
02347393 MENVEO - 72 MCG/DOSE meningococcal group a, c, w-135, y oligosaccharide, corynebacterium diphtheriae crm-197 protein vaccine J07AH Parenteral/Powder for solution blank Subj. Investigation
02239208 PRIORIX combined measles, mumps and rubella vaccine, live, attenuated J07BD Parenteral/Powder for solution blank Subj. Investigation
02297884 PRIORIX - TETRA combined measles, mumps, rubella and varicella vaccine, live, attenuated J07BD Parenteral/Powder for solution blank Within Guidelines
02300591 ROTARIX rotavirus vaccine (rix4414 strain), live, oral, attenuated (human) J07BH Oral Liquid/Powder for suspension blank Within Guidelines
02468425 SHINGRIX - 50 MCG/DOSE varicella-zoster virus glycoprotein e antigen J07BK Parenteral/Suspension or Emulsion blank Does Not Trigger
00657204 STIEVA-A CREAM - 0.1 MG/G tretinoin D10AD Topical/Cream blank Within Guidelines
00578576 STIEVA-A CREAM - 0.25 MG/G tretinoin D10AD Topical/Cream blank Within Guidelines
00518182 STIEVA-A CREAM - 0.5 MG/G tretinoin D10AD Topical/Cream blank Does Not Trigger
02320541 SYNFLORIX pneumococcal conjugate J07AL Parenteral/Suspension or Emulsion blank Within Guidelines
02474522 TRELEGY ELLIPTA 100/62.5/25 MCG/DOSE fluticasone furoate/umeclidinium/vilanterol R03AL Pulmonary/Powder blank Within Guidelines
02515776 TRELEGY ELLIPTA 200/62.5/25 MCG/DOSE fluticasone furoate/umeclidinium/vilanterol R03AL Pulmonary/Powder Introduced Under Review
02230578 TWINRIX 720/20 combined hepatitis a (inactivated) and hepatitis b (recombinant) vaccine J07BC Parenteral/Suspension or Emulsion blank Subj. Investigation
02237548 TWINRIX JUNIOR 360/10 combined hepatitis a (inactivated) and hepatitis b (recombinant) vaccine J07BC Parenteral/Suspension or Emulsion blank Subj. Investigation
02241047 VARILRIX varicella virus vaccine, live, attenuated (oka-strain) J07BK Parenteral/Powder for solution blank Within Guidelines
02307065 VOLIBRIS - 5 MG/TABLET ambrisentan C02KX Oral Solid/Tablet blank Within Guidelines
02307073 VOLIBRIS - 10 MG/TABLET ambrisentan C02KX Oral Solid/Tablet blank Within Guidelines
02489783 ZEJULA - 100 MG/CAPSULE niraparib tosylate L01XX Oral Solid/Capsule blank Within Guidelines
0886157 ZOVIRAX - 40 MG/ML acyclovir J05AB Oral Liquid/Suspension Expired Subj. Investigation
Grifols Canada Ltd
Grifols Canada Ltd
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02189100 PLASBUMIN-5 - 50 MG/ML albumin (human) B05AA Parenteral/Solution blank Subj. Investigation
02204606 PROLASTIN - 25 MG/ML alpha1-proteinase inhibitor (human) B02AB Parenteral/Powder for solution blank Within Guidelines

H

HLS Therapeutics Inc.
HLS Therapeutics Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02495244 VASCEPA - 1 G/CAPSULE icosapent ethyl C10AX Oral Solid/Capsule blank Within Guidelines
Hoffmann-La Roche Ltd
Hoffmann-La Roche Ltd
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02350092 ACTEMRA - 20 MG/ML tocilizumab L04AC Parenteral/Solution blank Within Guidelines
02350106 ACTEMRA - 20 MG/ML tocilizumab L04AC Parenteral/Solution blank Within Guidelines
02350114 ACTEMRA - 20 MG/ML tocilizumab L04AC Parenteral/Solution blank Does Not Trigger
02424770 ACTEMRA - 162 MG/SYRINGE tocilizumab L04AC Parenteral/Solution blank Within Guidelines
02483327 ACTEMRA - 162 MG/SYRINGE tocilizumab L04AC Parenteral/Solution blank Subj. Investigation
02225689 ACTIVASE - 50 MG/VIAL alteplase B01AD Parenteral/Solution blank Within Guidelines
02147440 ACTIVASE - 100 MG/VIAL alteplase B01AD Parenteral/Solution blank Within Guidelines
02458136 ALECENSARO - 150 MG/CAPSULE alectinib L01XE Oral Solid/Capsule blank Within Guidelines
02270994 AVASTIN - 25 MG/ML bevacizumab L01XC Parenteral/Solution blank Within Guidelines
02245859 CATHFLO - 2 MG/VIAL alteplase B01AD Parenteral/Solution blank Within Guidelines
02452340 COTELLIC - 20 MG/TABLET cobimetinib fumarate L01XE Oral Solid/Tablet blank Subj. Investigation
02499681 ENSPRYNG - 120 MG/ML satralizumab L04AC Parenteral/Solution blank Subj. Investigation
02409267 ERIVEDGE - 150 MG/CAPSULE vismodegib L01XX Oral Solid/Capsule blank Within Guidelines
02393751 ESBRIET - 267 MG/CAPSULE pirfenidone L04AX Oral Solid/Capsule blank Within Guidelines
02464489 ESBRIET - 267 MG/TABLET pirfenidone L04AX Oral Solid/Tablet blank Subj. Investigation
02464500 ESBRIET - 801 MG/TABLET pirfenidone L04AX Oral Solid/Tablet blank Within Guidelines
02514931 EVRYSDI - 0.75 MG/ML risdiplam M09AX Oral Liquid/Powder for solution Introduced Subj. Investigation
02434806 GAZYVA - 25 MG/ML obinutuzumab L01XC Parenteral/Solution blank Within Guidelines
02479621 HEMLIBRA - 30 MG/ML emicizumab B02BX Parenteral/Solution blank Subj. Investigation
02479648 HEMLIBRA - 60 MG/VIAL emicizumab B02BX Parenteral/Solution blank Within Guidelines
02479656 HEMLIBRA - 105 MG/VIAL emicizumab B02BX Parenteral/Solution blank Within Guidelines
02479664 HEMLIBRA - 150 MG/ML emicizumab B02BX Parenteral/Solution blank Subj. Investigation
02240692 HERCEPTIN - 21 MG/ML trastuzumab L01XC Parenteral/Solution blank Subj. Investigation
02480697 HERCEPTIN SC - 600 MG/VIAL trastuzumab L01XC Parenteral/Solution blank Subj. Investigation
02216965 INVIRASE - 200 MG/CAPSULE saquinavir mesylate J05AE Oral Solid/Capsule blank Within Guidelines
02279320 INVIRASE - 500 MG/TABLET saquinavir mesylate J05AE Oral Solid/Tablet blank Within Guidelines
02473224 KADCYLA - 20 MG/ML trastuzumab emtansine L01XC Parenteral/Powder for solution blank Subj. Investigation
02412365 KADCYLA - 20 MG/ML trastuzumab emtansine L01XC Parenteral/Powder for solution blank Subj. Investigation
02467224 OCREVUS - 30 MG/ML ocrelizumab L04AA Parenteral/Solution blank Subj. Investigation
02405016 PERJETA - 420 MG/VIAL pertuzumab L01XC Parenteral/Solution blank Within Guidelines
02405024 PERJETA-HERCEPTIN COMBO PACK 420/440 MG/VIAL pertuzumab/trastuzumab L01XY Parenteral/Other blank Within Guidelines
02512920 PHESGO 60/60 MG/ML pertuzumab/trastuzumab L01XY Parenteral/Solution Introduced Subj. Investigation
02512912 PHESGO 80/40 MG/ML pertuzumab/trastuzumab L01XY Parenteral/Solution Introduced Subj. Investigation
02515431 POLIVY - 30 MG/VIAL polatuzumab vedotin L01XC Parenteral/Powder for solution Introduced Under Review
02499614 POLIVY - 140 MG/VIAL polatuzumab vedotin L01XC Parenteral/Powder for solution blank Subj. Investigation
02241927 RITUXAN - 10 MG/ML rituximab L01XC Parenteral/Solution blank Within Guidelines
02457350 RITUXAN SC - 120 MG/ML rituximab L01XC Parenteral/Solution blank Within Guidelines
02473976 RITUXAN SC - 120 MG/ML rituximab L01XC Parenteral/Solution blank Within Guidelines
02495015 ROZLYTREK - 200 MG/CAPSULE entrectinib L01XE Oral Solid/Capsule blank Subj. Investigation
02381842 TAMIFLU (SEASONAL) - 6 MG/ML oseltamivir phosphate J05AH Oral Liquid/Powder for suspension blank Within Guidelines
02304848 TAMIFLU (SEASONAL) - 30 MG/CAPSULE oseltamivir phosphate J05AH Oral Solid/Capsule blank Does Not Trigger
02304856 TAMIFLU (SEASONAL) - 45 MG/CAPSULE oseltamivir phosphate J05AH Oral Solid/Capsule blank Does Not Trigger
02241472 TAMIFLU (SEASONAL) - 75 MG/CAPSULE oseltamivir phosphate J05AH Oral Solid/Capsule blank Subj. Investigation
02269007 TARCEVA - 25 MG/TABLET erlotinib hydrochloride L01XX Oral Solid/Tablet blank Does Not Trigger
02269015 TARCEVA - 100 MG/TABLET erlotinib hydrochloride L01XX Oral Solid/Tablet blank Does Not Trigger
02269023 TARCEVA - 150 MG/TABLET erlotinib hydrochloride L01XX Oral Solid/Tablet blank Does Not Trigger
02462990 TECENTRIQ - 60 MG/ML atezolizumab L01XC Parenteral/Solution blank Subj. Investigation
02492393 TECENTRIQ - 60 MG/ML atezolizumab L01XC Parenteral/Solution blank Subj. Investigation
02244826 TNKASE - 50 MG/VIAL tenecteplase B01AD Parenteral/Powder for solution blank Within Guidelines
02306085 VALCYTE - 50 MG/ML valganciclovir hydrochloride J05AB Oral Liquid/Powder for solution blank Within Guidelines
02245777 VALCYTE - 450 MG/TABLET valganciclovir hydrochloride J05AB Oral Solid/Tablet blank Does Not Trigger
02238453 XELODA - 150 MG/TABLET capecitabine L01BC Oral Solid/Tablet blank Within Guidelines
02238454 XELODA - 500 MG/TABLET capecitabine L01BC Oral Solid/Tablet blank Within Guidelines
02380242 ZELBORAF - 240 MG/TABLET vemurafenib L01XE Oral Solid/Tablet blank Subj. Investigation
Horizon Therapeutics Canada
Horizon Therapeutics Canada
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
ACTIMMUNE - 100 MCG/VIAL interferon gamma 1b L03AB Parenteral/Solution blank Does Not Trigger
02464705 PROCYSBI - 25 MG/CAPSULE cysteamine bitartrate A16AA Oral Solid/Modified release capsule blank NOH
02464713 PROCYSBI - 75 MG/CAPSULE cysteamine bitartrate A16AA Oral Solid/Modified release capsule blank NOH
02442302 QUINSAIR - 100 MG/ML levofloxacin J01MA Pulmonary/Solution blank Within Guidelines

I

Incyte Biosciences Canada Corporation
Incyte Biosciences Canada Corporation
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02518627 MINJUVI - 200 MG/VIAL tafasitamab L01XC Parenteral/Powder for solution Introduced Under Review
Indivior Canada Ltd
Indivior Canada Ltd
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02483084 SUBLOCADE - 100 MG/SYRINGE buprenorphine N07BC Parenteral/Solution (extended release) blank Subj. Investigation
02483092 SUBLOCADE - 300 MG/SYRINGE buprenorphine N07BC Parenteral/Solution (extended release) blank Subj. Investigation
02502313 SUBOXONE 2/0.5 MG/FILM buprenorphine/naloxone N07BC Oral Solid/Other blank Subj. Investigation
02502321 SUBOXONE 4/1 MG/FILM buprenorphine/naloxone  N07BC Oral Solid/Other Introduced Under Review
02502348 SUBOXONE 8/2 MG/FILM buprenorphine/naloxone N07BC Oral Solid/Other blank Subj. Investigation
02502356 SUBOXONE 12/3 MG/FILM buprenorphine/naloxone N07BC Oral Solid/Other blank Subj. Investigation
Insmed Inc.
Insmed Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
ARIKAYCE - 590 MG/VIAL amikacin liposome inhalation suspension (alis) blank Pulmonary/Solution Introduced Under Review
Intercept Pharmaceuticals Inc.
Intercept Pharmaceuticals Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02463121 OCALIVA - 5 MG/TABLET obeticholic acid A05AA Oral Solid/Tablet blank Does Not Trigger
02463148 OCALIVA - 10 MG/TABLET obeticholic acid A05AA Oral Solid/Tablet blank Within Guidelines
Ipsen Biopharmaceuticals Canada Inc.
Ipsen Biopharmaceuticals Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02480824 CABOMETYX - 20 MG/TABLET cabozantinib L01XE Oral Solid/Tablet blank Within Guidelines
02480832 CABOMETYX - 40 MG/TABLET cabozantinib L01XE Oral Solid/Tablet blank Within Guidelines
02480840 CABOMETYX - 60 MG/TABLET cabozantinib L01XE Oral Solid/Tablet blank Within Guidelines
02387735 DYSPORT AESTHETIC - 300 UNIT/VIAL abobotulinumtoxinA M03AX Parenteral/Powder for solution blank Within Guidelines
02460203 DYSPORT THERAPEUTIC - 300 UNIT/VIAL abobotulinumtoxinA M03AX Parenteral/Powder for solution blank Subj. Investigation
02456117 DYSPORT THERAPEUTIC - 500 UNIT/VIAL abobotulinumtoxinA M03AX Parenteral/Powder for solution blank Subj. Investigation
02509733 INCRELEX - 10 MG/ML mecasermin H01AC Parenteral/Solution Expired Subj. Investigation
02283395 SOMATULINE AUTOGEL - 60 MG/SYRINGE lanreotide H01CB Parenteral/Solution blank Subj. Investigation
02283409 SOMATULINE AUTOGEL - 90 MG/SYRINGE lanreotide H01CB Parenteral/Solution blank Within Guidelines
02283417 SOMATULINE AUTOGEL - 120 MG/SYRINGE lanreotide H01CB Parenteral/Solution blank Within Guidelines
02481553 XERMELO - 250 MG/TABLET telotristat ethyl A16AX Oral Solid/Tablet blank Within Guidelines

J

Janssen Inc.
Janssen Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02493217 BALVERSA - 3 MG/TABLET erdafitinib L01XE Oral Solid/Tablet blank Within Guidelines
02493225 BALVERSA - 4 MG/TABLET erdafitinib L01XE Oral Solid/Tablet blank Does Not Trigger
02493233 BALVERSA - 5 MG/TABLET erdafitinib L01XE Oral Solid/Tablet blank Within Guidelines
02397447 CARIPUL - 0.5 MG/VIAL epoprostenol sodium B01AC Parenteral/Powder for solution blank Does Not Trigger
02397455 CARIPUL - 1.5 MG/VIAL epoprostenol sodium B01AC Parenteral/Powder for solution blank Does Not Trigger
02455951 DARZALEX - 100 MG/VIAL daratumumab L01FC Parenteral/Solution blank Within Guidelines
02455978 DARZALEX - 400 MG/VIAL daratumumab L01FC Parenteral/Solution blank Within Guidelines
02502712 DARZALEX SC - 1800 MG/VIAL daratumumab L01FC Parenteral/Solution blank Within Guidelines
02370603 EDURANT - 25 MG/TABLET rilpivirine hydrochloride J05AG Oral Solid/Tablet blank Does Not Trigger
02231583 EPREX - 1000 UNIT/SYRINGE epoetin alfa B03XA Parenteral/Solution blank Within Guidelines
02231584 EPREX - 2000 UNIT/SYRINGE epoetin alfa B03XA Parenteral/Solution blank Within Guidelines
02231585 EPREX - 3000 UNIT/SYRINGE epoetin alfa B03XA Parenteral/Solution blank Within Guidelines
02231586 EPREX - 4000 UNIT/SYRINGE epoetin alfa B03XA Parenteral/Solution blank Within Guidelines
02243400 EPREX - 5000 UNIT/SYRINGE epoetin alfa B03XA Parenteral/Solution blank Within Guidelines
02243401 EPREX - 6000 UNIT/SYRINGE epoetin alfa B03XA Parenteral/Solution blank Within Guidelines
02243403 EPREX - 8000 UNIT/SYRINGE epoetin alfa B03XA Parenteral/Solution blank Within Guidelines
02231587 EPREX - 10000 UNIT/ML epoetin alfa B03XA Parenteral/Solution blank Within Guidelines
02243239 EPREX - 20000 UNIT/SYRINGE epoetin alfa B03XA Parenteral/Solution blank Within Guidelines
02288680 EPREX - 30000 UNIT/SYRINGE epoetin alfa B03XA Parenteral/Solution blank Subj. Investigation
02240722 EPREX - 40000 UNIT/ML epoetin alfa B03XA Parenteral/Solution blank Within Guidelines
02478374 ERLEADA - 60 MG/TABLET apalutamide  L02BB Oral Solid/Tablet blank Within Guidelines
02434407 IMBRUVICA - 140 MG/CAPSULE ibrutinib L01XE Oral Solid/Capsule blank Within Guidelines
02306778 INTELENCE - 100 MG/TABLET etravirine J05AG Oral Solid/Tablet blank Within Guidelines
02375931 INTELENCE - 200 MG/TABLET etravirine J05AG Oral Solid/Tablet blank Within Guidelines
02300273 INVEGA - 3 MG/TABLET paliperidone N05AX Oral Solid/Modified release tablet blank Within Guidelines
02300281 INVEGA - 6 MG/TABLET paliperidone N05AX Oral Solid/Modified release tablet blank Within Guidelines
02300303 INVEGA - 9 MG/TABLET paliperidone N05AX Oral Solid/Modified release tablet blank Within Guidelines
02354217 INVEGA SUSTENNA - 50 MG/SYRINGE paliperidone palmitate N05AX Parenteral/Modified release injection blank Within Guidelines
02354225 INVEGA SUSTENNA - 75 MG/SYRINGE paliperidone palmitate N05AX Parenteral/Modified release injection blank Within Guidelines
02354233 INVEGA SUSTENNA - 100 MG/SYRINGE paliperidone palmitate N05AX Parenteral/Modified release injection blank Within Guidelines
02354241 INVEGA SUSTENNA - 150 MG/SYRINGE paliperidone palmitate N05AX Parenteral/Modified release injection blank Within Guidelines
02455943 INVEGA TRINZA - 175 MG/SYRINGE paliperidone palmitate N05AX Parenteral/Suspension (extended release) blank Within Guidelines
02455986 INVEGA TRINZA - 263 MG/SYRINGE paliperidone palmitate N05AX Parenteral/Suspension (extended release) blank Within Guidelines
02455994 INVEGA TRINZA - 350 MG/SYRINGE paliperidone palmitate N05AX Parenteral/Suspension (extended release) blank Within Guidelines
02456001 INVEGA TRINZA - 525 MG/SYRINGE paliperidone palmitate N05AX Parenteral/Suspension (extended release) blank Within Guidelines
02455404 INVOKAMET 50/500 MG/TABLET canagliflozin/metformin hydrochloride A10BD Oral Solid/Tablet blank Within Guidelines
02455420 INVOKAMET 50/1000 MG/TABLET canagliflozin/metformin hydrochloride A10BD Oral Solid/Tablet blank Within Guidelines
02455439 INVOKAMET 150/500 MG/TABLET canagliflozin/metformin hydrochloride A10BD Oral Solid/Tablet blank Does Not Trigger
02455455 INVOKAMET 150/1000 MG/TABLET canagliflozin/metformin hydrochloride A10BD Oral Solid/Tablet blank Within Guidelines
02425483 INVOKANA - 100 MG/TABLET canagliflozin A10BX Oral Solid/Tablet blank Within Guidelines
02425491 INVOKANA - 300 MG/TABLET canagliflozin A10BX Oral Solid/Tablet blank Within Guidelines
02513153 JANSSEN COVID-19 VACCINE - 0.5 ML/DOSE sars-cov-2 vaccine [ad26.cov2.s, recombinant] J07BX Parenteral/Solution Introduced Under Review
02415690 OPSUMIT - 10 MG/TABLET macitentan C02KX Oral Solid/Tablet blank Within Guidelines
02521083 OPSYNVI  - 50 MG/TABLET macitentan/tadalafil C02KX   Oral Solid/Tablet Introduced Under Review
02515474 PONVORY ponesimod L04AA Oral Solid/Tablet Introduced Under Review
02515482 PONVORY - 20 MG/TABLET ponesimod L04AA Oral Solid/Tablet Introduced Under Review
02426501 PREZCOBIX 800/150 MG/TABLET darunavir/cobicistat J05AR Oral Solid/Tablet blank Does Not Trigger
02338432 PREZISTA - 75 MG/TABLET darunavir ethanolate J05AE Oral Solid/Tablet blank Does Not Trigger
02369753 PREZISTA - 150 MG/TABLET darunavir ethanolate J05AE Oral Solid/Tablet blank Does Not Trigger
02324024 PREZISTA - 600 MG/TABLET darunavir ethanolate J05AE Oral Solid/Tablet blank Within Guidelines
02393050 PREZISTA - 800 MG/TABLET darunavir ethanolate J05AE Oral Solid/Tablet blank Within Guidelines
02236950 RISPERDAL - 1 MG/ML risperidone N05AX Oral Liquid/Solution Expired Does Not Trigger
02298465 RISPERDAL CONSTA - 12.5 MG/VIAL risperidone N05AX Parenteral/Modified release injection Expired Within Guidelines
02255707 RISPERDAL CONSTA - 25 MG/VIAL risperidone N05AX Parenteral/Modified release injection Expired Within Guidelines
02255723 RISPERDAL CONSTA - 37.5 MG/VIAL risperidone N05AX Parenteral/Modified release injection Expired Within Guidelines
02255758 RISPERDAL CONSTA - 50 MG/VIAL risperidone N05AX Parenteral/Modified release injection Expired Within Guidelines
02324776 SIMPONI - 50 MG/SYRINGE golimumab L04AB Parenteral/Solution Expired Within Guidelines
02324784 SIMPONI - 50 MG/SYRINGE golimumab L04AB Parenteral/Solution Expired Within Guidelines
02417472 SIMPONI - 50 MG/VIAL golimumab L04AB Parenteral/Solution Expired Within Guidelines
02413183 SIMPONI - 100 MG/ML golimumab L04AB Parenteral/Solution Expired Within Guidelines
02413175 SIMPONI - 100 MG/SYRINGE golimumab L04AB Parenteral/Solution Expired Within Guidelines
02320673 STELARA - 45 MG/VIAL ustekinumab L04AC Parenteral/Solution blank Within Guidelines
02320681 STELARA - 90 MG/VIAL ustekinumab L04AC Parenteral/Solution blank Within Guidelines
02459671 STELARA - 130 MG/VIAL ustekinumab L04AC Parenteral/Solution blank Within Guidelines
02473720 SYMTUZA 800/150/200/10 darunavir/cobicistat/emtricitabine/tenofovir alafenamide J05AR Oral Solid/Tablet blank Does Not Trigger
02337630 TOCTINO - 10 MG/CAPSULE alitretinoin D11AX Oral Solid/Capsule blank Within Guidelines
02337649 TOCTINO - 30 MG/CAPSULE alitretinoin D11AX Oral Solid/Capsule blank Within Guidelines
02244981 TRACLEER - 62.5 MG/TABLET bosentan monohydrate C02KX Oral Solid/Tablet Expired Does Not Trigger
02244982 TRACLEER - 125 MG/TABLET bosentan monohydrate C02KX Oral Solid/Tablet Expired Within Guidelines
02469758 TREMFYA - 100 MG/ML guselkumab L04AC Parenteral/Solution blank Within Guidelines
02487314 TREMFYA ONE-PRESS - 100 MG/ML guselkumab L04AC Parenteral/Solution blank Within Guidelines
02451158 UPTRAVI - 200 MCG/TABLET selexipag B01AC Oral Solid/Tablet blank Does Not Trigger
02451166 UPTRAVI - 400 MCG/TABLET selexipag B01AC Oral Solid/Tablet blank Within Guidelines
02451174 UPTRAVI - 600 MCG/TABLET selexipag B01AC Oral Solid/Tablet blank Within Guidelines
02451182 UPTRAVI - 800 MCG/TABLET selexipag B01AC Oral Solid/Tablet blank Within Guidelines
02451190 UPTRAVI - 1000 MCG/TABLET selexipag B01AC Oral Solid/Tablet blank Within Guidelines
02451204 UPTRAVI - 1200 MCG/TABLET selexipag B01AC Oral Solid/Tablet blank Within Guidelines
02451212 UPTRAVI - 1400 MCG/TABLET selexipag B01AC Oral Solid/Tablet blank Within Guidelines
02451220 UPTRAVI - 1600 MCG/TABLET selexipag B01AC Oral Solid/Tablet blank Within Guidelines
02262452 VELCADE - 3.5 MG/VIAL bortezomib L01XX Parenteral/Powder for solution blank Does Not Trigger
02371065 ZYTIGA - 250 MG/TABLET abiraterone acetate L02BX Oral Solid/Tablet blank Within Guidelines
02457113 ZYTIGA - 500 MG/TABLET abiraterone acetate L02BX Oral Solid/Tablet blank Within Guidelines
Jazz Pharmaceuticals PLC
Jazz Pharmaceuticals PLC
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02465981 DEFITELIO - 200 MG/VIAL defibrotide sodium B01AX Parenteral/Solution blank Within Guidelines
02268272 XYREM - 500 MG/ML sodium oxybate N07XX Oral Liquid/Solution blank Within Guidelines
Johnson & Johnson Medical Products
Johnson & Johnson Medical Products
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02348497 EVICEL thrombin (human)/fibrinogen (human) B02BC Topical/Liquid blank Within Guidelines

K

Knight Therapeutics Inc.
Knight Therapeutics Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02442167 MOVANTIK - 12.5 MG/TABLET naloxegol oxalate A06AH Oral Solid/Tablet blank Does Not Trigger
02442175 MOVANTIK - 25 MG/TABLET naloxegol oxalate A06AH Oral Solid/Tablet blank Does Not Trigger
02490536 NERLYNX - 40 MG/TABLET neratinib L01XE Oral Solid/Tablet blank VCU
02474921 PROBUPHINE - 80 MG/IMPLANT buprenorphine hydrochloride N07BC Parenteral/Implant blank Within Guidelines
Kyowa Kirin Inc.
Kyowa Kirin Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
POTELIGEO - 4 MG/ML mogamulizumab L01XC Parenteral/Solution Introduced Under Review

L

Labtician Théa
Labtician Théa
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02456230 MONOPROST - 0.2 ML/DOSE latanoprost S01EE Ophthalmic/Solution blank Subj. Investigation
Lantheus Mi Canada Inc.
Lantheus Mi Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02243173 DEFINITY - 150 MCL/ML perflutren V08DA Parenteral/Suspension or Emulsion blank Within Guidelines
Leo Pharma Inc.
Leo Pharma Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02319012 DOVOBET GEL 0.05/0.5 MG/G calcipotriol/betamethasone dipropionate D05AX Topical/Gel Expired Within Guidelines
02457393 ENSTILAR - 0.55 MG/G calcipotriol/betamethasone dipropionate D05AX Topical/Aerosol (foam) blank Within Guidelines
Lundbeck Canada Inc.
Lundbeck Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02432919 TRINTELLIX - 5 MG/TABLET vortioxetine hydrobromide N06AX Oral Solid/Tablet blank Within Guidelines
02432927 TRINTELLIX - 10 MG/TABLET vortioxetine hydrobromide N06AX Oral Solid/Tablet blank Within Guidelines
02432943 TRINTELLIX - 20 MG/TABLET vortioxetine hydrobromide N06AX Oral Solid/Tablet blank Within Guidelines
Lupin Pharma Canada Ltd
Lupin Pharma Canada Ltd
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02308215 RELISTOR - 20 MG/ML methylnaltrexone bromide A06AH Parenteral/Solution blank Within Guidelines
02410702 ZAXINE - 550 MG/TABLET rifaximin A07AA Oral Solid/Tablet blank Within Guidelines

M

Medexus Inc.
Medexus Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02454831 METOJECT SUBCUTANEOUS - 10 MG/SYRINGE methotrexate sodium L04AX Parenteral/Solution blank Within Guidelines
02454750 METOJECT SUBCUTANEOUS - 12.5 MG/SYRINGE methotrexate sodium L04AX Parenteral/Solution blank Within Guidelines
02454858 METOJECT SUBCUTANEOUS - 15 MG/SYRINGE methotrexate sodium L04AX Parenteral/Solution blank Within Guidelines
02454769 METOJECT SUBCUTANEOUS - 17.5 MG/SYRINGE methotrexate sodium L04AX Parenteral/Solution blank Within Guidelines
02454866 METOJECT SUBCUTANEOUS - 20 MG/SYRINGE methotrexate sodium L04AX Parenteral/Solution blank Within Guidelines
02454777 METOJECT SUBCUTANEOUS - 22.5 MG/SYRINGE methotrexate sodium L04AX Parenteral/Solution blank Within Guidelines
02454874 METOJECT SUBCUTANEOUS - 25 MG/SYRINGE methotrexate sodium L04AX Parenteral/Solution blank Within Guidelines
Medison Pharma Canada Inc.
Medison Pharma Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02500833 QINLOCK - 50 MG/TABLET ripretinib L01XE Oral Solid/Tablet Introduced Subj. Investigation
02508052 TAVALISSE - 100 MG/TABLET fostamatinib B02BX Oral Solid/Tablet Introduced Subj. Investigation
02508060 TAVALISSE - 150 MG/TABLET fostamatinib B02BX Oral Solid/Tablet Introduced Within Guidelines
Merck Canada Inc.
Merck Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02482592 DELSTRIGO 100/300/300 MG/TABLET doravirine/lamivudine/tenofovir disoproxil fumarate J05AR Oral Solid/Tablet blank Does Not Trigger
02387174 DIFICID - 200 MG/TABLET fidaxomicin A07AA Oral Solid/Tablet blank Within Guidelines
02437058 GARDASIL 9 human papillomavirus 9-valent vaccine recombinant J07BM Parenteral/Suspension or Emulsion blank Within Guidelines
02240351 INTEGRILIN - 0.75 MG/ML eptifibatide B01AC Parenteral/Solution blank Subj. Investigation
02240352 INTEGRILIN - 2 MG/ML eptifibatide B01AC Parenteral/Solution blank Subj. Investigation
02238674 INTRON-A - 6000000 UNIT/ML interferon alfa-2b L03AB Parenteral/Solution blank Subj. Investigation
02238675 INTRON-A - 10000000 UNIT/ML interferon alfa-2b L03AB Parenteral/Solution blank Does Not Trigger
02223406 INTRON-A - 10000000 UNIT/VIAL interferon alfa-2b L03AB Parenteral/Powder for solution blank Within Guidelines
02240693 INTRON-A PEN HSA FREE - 15000000 UNIT/ML interferon alfa-2b L03AB Parenteral/Solution blank Subj. Investigation
02247437 INVANZ - 1000 MG/VIAL ertapenem sodium J01DH Parenteral/Powder for solution blank Within Guidelines
02392429 ISENTRESS - 25 MG/TABLET raltegravir potassium J05AX Oral Solid/Tablet blank Does Not Trigger
02392437 ISENTRESS - 100 MG/TABLET raltegravir potassium J05AX Oral Solid/Tablet blank Does Not Trigger
02301881 ISENTRESS - 400 MG/TABLET raltegravir potassium J05AX Oral Solid/Tablet blank Within Guidelines
02465337 ISENTRESS HD - 600 MG/TABLET raltegravir potassium J05AX Oral Solid/Tablet blank Within Guidelines
02333856 JANUMET 50/500 MG/TABLET sitagliptin phosphate monohydrate/metformin hydrochloride A10BD Oral Solid/Tablet blank Subj. Investigation
02333864 JANUMET 50/850 MG/TABLET sitagliptin phosphate monohydrate/metformin hydrochloride A10BD Oral Solid/Tablet blank Subj. Investigation
02333872 JANUMET 50/1000 MG/TABLET sitagliptin phosphate monohydrate/metformin hydrochloride A10BD Oral Solid/Tablet blank Subj. Investigation
02416786 JANUMET XR 50/500 MG/TABLET sitagliptin phosphate monohydrate/metformin hydrochloride A10BD Oral Solid/Modified release tablet blank Subj. Investigation
02416794 JANUMET XR 50/1000 MG/TABLET sitagliptin phosphate monohydrate/metformin hydrochloride A10BD Oral Solid/Modified release tablet blank Within Guidelines
02416808 JANUMET XR 100/1000 MG/TABLET sitagliptin phosphate monohydrate/metformin hydrochloride A10BD Oral Solid/Modified release tablet blank Subj. Investigation
02388839 JANUVIA - 25 MG/TABLET sitagliptin phosphate monohydrate A10BH Oral Solid/Tablet blank Within Guidelines
02388847 JANUVIA - 50 MG/TABLET sitagliptin phosphate monohydrate A10BH Oral Solid/Tablet blank Within Guidelines
02303922 JANUVIA - 100 MG/TABLET sitagliptin phosphate monohydrate A10BH Oral Solid/Tablet blank Within Guidelines
02441152 KEYTRUDA - 50 MG/VIAL pembrolizumab L01XC Parenteral/Powder for solution blank Within Guidelines
02456869 KEYTRUDA - 100 MG/VIAL pembrolizumad L01XC Parenteral/Solution blank Within Guidelines
02481545 PIFELTRO - 100 MG/TABLET doravirine J05AG Oral Solid/Tablet blank Within Guidelines
02293404 POSANOL - 40 MG/ML posaconazole J02AC Oral Liquid/Suspension blank Within Guidelines
02424622 POSANOL - 100 MG/TABLET posaconazole J02AC Oral Solid/Tablet blank Within Guidelines
02432676 POSANOL - 300 MG/VIAL posaconazole J02AC Parenteral/Solution blank Within Guidelines
02469375 PREVYMIS - 240 MG/TABLET letermovir J05AX Oral Solid/Tablet blank Subj. Investigation
02469383 PREVYMIS - 480 MG/TABLET letermovir J05AX Oral Solid/Tablet blank Subj. Investigation
02469367 PREVYMIS - 240 MG/VIAL letermovir J05AX Parenteral/Solution blank Subj. Investigation
02469405 PREVYMIS - 480 MG/VIAL letermovir J05AX Parenteral/Solution blank Subj. Investigation
02451131 ZEPATIER 50/100 MG/TABLET elbasvir/grazoprevir J05AX Oral Solid/Tablet blank Within Guidelines
02327619 ZOLINZA - 100 MG/CAPSULE vorinostat L01XX Oral Solid/Capsule blank Within Guidelines
Merz Pharma Canada Ltd
Merz Pharma Canada Ltd
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02371081 XEOMIN - 50 UNIT/VIAL incobotulinumtoxina M03AX Parenteral/Powder for solution blank Within Guidelines
02324032 XEOMIN - 100 UNIT/VIAL incobotulinumtoxina M03AX Parenteral/Powder for solution blank Within Guidelines
02383489 XEOMIN COSMETIC - 100 UNIT/VIAL incobotulinumtoxina M03AX Parenteral/Powder for solution blank Subj. Investigation

N

Noden Pharma DAC
Noden Pharma DAC
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02302063 RASILEZ - 150 MG/TABLET aliskiren fumarate C09XA  Oral Solid/Tablet blank Within Guidelines
02302071 RASILEZ - 300 MG/TABLET aliskiren fumarate C09XA  Oral Solid/Tablet blank Within Guidelines
02332728 RASILEZ HCT 150/12.5 MG/TABLET aliskiren fumarate/hydrochlorothiazide C09XA Oral Solid/Tablet blank Does Not Trigger
Novartis Pharmaceuticals Canada Inc.
Novartis Pharmaceuticals Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02269198 ACLASTA - 5 MG/VIAL zoledronic acid M05BA Parenteral/Solution Expired Within Guidelines
02369257 AFINITOR - 2.5 MG/TABLET everolimus L04AA Oral Solid/Tablet blank Within Guidelines
02339501 AFINITOR - 5 MG/TABLET everolimus L04AA Oral Solid/Tablet blank Within Guidelines
02339528 AFINITOR - 10 MG/TABLET everolimus L04AA Oral Solid/Tablet blank Within Guidelines
02425645 AFINITOR DISPERZ - 2 MG/TABLET everolimus L04AA Oral Solid/Tablet blank Within Guidelines
02425653 AFINITOR DISPERZ - 3 MG/TABLET everolimus L04AA Oral Solid/Tablet blank Within Guidelines
02425661 AFINITOR DISPERZ - 5 MG/TABLET everolimus L04AA Oral Solid/Tablet blank Within Guidelines
02479613 AIMOVIG - 70 MG/ML erenumab N02CX Parenteral/Solution blank Within Guidelines
02487306 AIMOVIG - 140 MG/ML erenumab N02CX Parenteral/Solution blank Within Guidelines
02331624 AZARGA 1/0.5 brinzolamide/timolol maleate S01ED Ophthalmic/Suspension blank Within Guidelines
02238873 AZOPT - 10 MG/ML brinzolamide S01EC Ophthalmic/Suspension blank Within Guidelines
02496976 BEOVU - 6 MG/SYRINGE brolucizumab S01LA Parenteral/Solution blank Does Not Trigger
02252716 CIPRODEX 3/1 MG/ML ciprofloxacin hydrochloride/dexamethasone S02CA Otic/Suspension blank Within Guidelines
02438070 COSENTYX - 150 MG/ML secukinumab L04AC Parenteral/Solution blank Within Guidelines
02278251 DUO TRAV PQ  0.04/5 MG/ML travoprost/timolol maleate S01ED Ophthalmic/Liquid blank Subj. Investigation
02446928 ENTRESTO 24.3/25.7 MG/TABLET sacubitril/valsartan C09DX Oral Solid/Tablet blank Within Guidelines
02446936 ENTRESTO 48.6/51.4 MG/TABLET sacubitril/valsartan C09DX Oral Solid/Tablet blank Within Guidelines
02446944 ENTRESTO 97.2/102.8 MG/TABLET sacubitril/valsartan C09DX Oral Solid/Tablet blank Within Guidelines
02287420 EXJADE - 125 MG/TABLET deferasirox V03AC Oral Solid/Tablet blank Within Guidelines
02287439 EXJADE - 250 MG/TABLET deferasirox V03AC Oral Solid/Tablet blank Within Guidelines
02287447 EXJADE - 500 MG/TABLET deferasirox V03AC Oral Solid/Tablet blank Within Guidelines
02337819 EXTAVIA - 0.3 MG/VIAL interferon beta-1b L03AB Parenteral/Powder for solution Expired Within Guidelines
02482533 GILENYA - 0.25 MG/CAPSULE fingolimod hydrochloride L04AA Oral Solid/Capsule blank Within Guidelines
02365480 GILENYA - 0.5 MG/CAPSULE fingolimod hydrochloride L04AA Oral Solid/Capsule blank Within Guidelines
02253275 GLEEVEC - 100 MG/TABLET imatinib mesylate L01XX Oral Solid/Tablet blank Within Guidelines
02253283 GLEEVEC - 400 MG/TABLET imatinib mesylate L01XX Oral Solid/Tablet blank Within Guidelines
02460351 ILARIS - 150 MG/ML canakinumab L04AC Parenteral/Solution blank Within Guidelines
02411393 ILEVRO - 3 MG/ML nepafenac S01BC Ophthalmic/Suspension blank Within Guidelines
02457997 IZBA - 0.03 MG/ML travoprost S01EE Ophthalmic/Liquid blank Within Guidelines
02452219 JADENU - 90 MG/TABLET deferasirox V03AC Oral Solid/Tablet blank Within Guidelines
02452227 JADENU - 180 MG/TABLET deferasirox V03AC Oral Solid/Tablet blank Within Guidelines
02452235 JADENU - 360 MG/TABLET deferasirox V03AC Oral Solid/Tablet blank Within Guidelines
02388006 JAKAVI - 5 MG/TABLET ruxolitinib L01XE Oral Solid/Tablet blank Within Guidelines
02434814 JAKAVI - 10 MG/TABLET ruxolitinib L01XE Oral Solid/Tablet blank Within Guidelines
02388014 JAKAVI - 15 MG/TABLET ruxolitinib L01XE Oral Solid/Tablet blank Within Guidelines
02388022 JAKAVI - 20 MG/TABLET ruxolitinib L01XE Oral Solid/Tablet blank Within Guidelines
02511355 KESIMPTA - 20 MG/PEN ofatumumab L01XC Parenteral/Solution Introduced Does Not Trigger
02473569 KISQALI - 200 MG/TABLET ribociclib L01XE Oral Solid/Tablet blank Within Guidelines
02480514 KYMRIAH tisagenlecleucel L01XX Parenteral/Other blank Within Guidelines
02496429 MAYZENT - 0.25 MG/TABLET siponimod L04AA Oral Solid/Tablet blank Within Guidelines
02496437 MAYZENT - 2 MG/TABLET siponimod L04AA Oral Solid/Tablet blank Within Guidelines
02409623 MEKINIST - 0.5 MG/TABLET trametinib L01XE Oral Solid/Tablet blank Within Guidelines
02409658 MEKINIST - 2 MG/TABLET trametinib L01XE Oral Solid/Tablet blank Within Guidelines
02264560 MYFORTIC - 180 MG/TABLET mycophenolate sodium L04AA Oral Solid/Tablet blank Within Guidelines
02264579 MYFORTIC - 360 MG/TABLET mycophenolate sodium L04AA Oral Solid/Tablet blank Within Guidelines
02308983 NEVANAC - 1 MG/ML nepafenac S01BC Ophthalmic/Suspension blank Within Guidelines
02376938 ONBREZ BREEZHALER - 75 MCG/CAPSULE indacaterol maleate R03AC Pulmonary/Powder blank Within Guidelines
02362171 PATADAY - 2 MG/ML olopatadine hydrochloride S01GX Ophthalmic/Liquid blank Subj. Investigation
02233143 PATANOL - 1 MG/ML olopatadine hydrochloride S01GX Ophthalmic/Liquid blank Subj. Investigation
02458551 PAZEO - 7 MG/ML olopatadine hydrochloride S01GX Ophthalmic/Liquid blank Within Guidelines
02497069 PIQRAY - 150 MG/TABLET alpelisib L01XX Oral Solid/Tablet blank Within Guidelines
02497077 PIQRAY - 200 MG/TABLET alpelisib L01XX Oral Solid/Tablet blank Within Guidelines
02497085 PIQRAY 50/200 MG/TABLET alpelisib L01XX Oral Solid/Tablet blank Within Guidelines
02361825 REVOLADE - 25 MG/TABLET eltrombopag olamine B02BX Oral Solid/Tablet blank Within Guidelines
02361833 REVOLADE - 50 MG/TABLET eltrombopag olamine B02BX Oral Solid/Tablet blank Within Guidelines
02466236 RYDAPT - 25 MG/CAPSULE midostaurin L01XE Oral Solid/Capsule blank Within Guidelines
00839191 SANDOSTATIN - 0.05 MG/ML octreotide H01CB Parenteral/Solution blank Within Guidelines
00839205 SANDOSTATIN - 0.1 MG/ML octreotide H01CB Parenteral/Solution blank Within Guidelines
02049392 SANDOSTATIN - 0.2 MG/ML octreotide H01CB Parenteral/Solution blank Within Guidelines
02239323 SANDOSTATIN LAR - 10 MG/VIAL octreotide H01CB Parenteral/Modified release injection blank Within Guidelines
02239324 SANDOSTATIN LAR - 20 MG/VIAL octreotide H01CB Parenteral/Modified release injection blank Within Guidelines
02239325 SANDOSTATIN LAR - 30 MG/VIAL octreotide H01CB Parenteral/Modified release injection blank Within Guidelines
02394936 SEEBRI BREEZHALER - 50 MCG/CAPSULE glycopyrronium bromide R03BB Pulmonary/Powder blank Within Guidelines
02435411 SIMBRINZA brinzolamide/brimonidine tartrate S01EC Ophthalmic/Suspension blank Within Guidelines
02409607 TAFINLAR - 50 MG/CAPSULE dabrafenib L01XE Oral Solid/Capsule blank Within Guidelines
02409615 TAFINLAR - 75 MG/CAPSULE dabrafenib L01XE Oral Solid/Capsule blank Within Guidelines
02368250 TASIGNA - 150 MG/CAPSULE nilotinib hydrochloride monohydrate L01XE Oral Solid/Capsule blank Within Guidelines
02315874 TASIGNA - 200 MG/CAPSULE nilotinib hydrochloride monohydrate L01XE Oral Solid/Capsule blank Within Guidelines
02318008 TRAVATAN Z - 0.04 MG/ML travoprost S01EE Ophthalmic/Liquid blank Within Guidelines
02368676 TRIESENCE - 40 MG/ML triamcinolone acetonide S01BA Ophthalmic/Other blank Does Not Trigger
02326442 TYKERB - 250 MG/TABLET lapatinib ditosylate monohydrate L01XE Oral Solid/Tablet blank Within Guidelines
02418282 ULTIBRO BREEZHALER 110/50 MCG/CAPSULE indacaterol maleate/glycopyrronium bromide R03AL Pulmonary/Powder blank Subj. Investigation
02352303 VOTRIENT - 200 MG/TABLET pazopanib hydrochloride L01XE Oral Solid/Tablet Expired Within Guidelines
02471027 XIIDRA - 50 MG/ML lifitegrast S01XA Ophthalmic/Solution blank Within Guidelines
02459787 XOLAIR - 75 MG/SYRINGE omalizumab R03DX Parenteral/Solution blank Within Guidelines
02459795 XOLAIR - 150 MG/SYRINGE omalizumab R03DX Parenteral/Solution blank Within Guidelines
02260565 XOLAIR - 150 MG/VIAL omalizumab R03DX Parenteral/Powder for solution blank Within Guidelines
02509695 ZOLGENSMA onasemnogene abeparvovec M09AX Parenteral/Kit blank Subj. Investigation
02436779 ZYKADIA - 150 MG/CAPSULE ceritinib L01XE Oral Solid/Capsule blank Does Not Trigger
Novo Nordisk Canada Inc.
Novo Nordisk Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02470187 REBINYN coagulation factor ix (recombinant), pegylated B02BD Parenteral/Powder for solution blank Within Guidelines
02470268 REBINYN coagulation factor ix (recombinant), pegylated B02BD Parenteral/Powder for solution blank Within Guidelines
02470276 REBINYN coagulation factor ix (recombinant), pegylated B02BD Parenteral/Powder for solution blank Within Guidelines
02389975 TRETTEN - 15 MG/VIAL catridecacog B02BD Parenteral/Powder for solution blank Within Guidelines
02435187 ZONOVATE turoctocog alfa B02BD Parenteral/Powder for solution blank Within Guidelines
02435195 ZONOVATE turoctocog alfa B02BD Parenteral/Powder for solution blank Within Guidelines
02435209 ZONOVATE turoctocog alfa B02BD Parenteral/Powder for solution blank Within Guidelines
02435225 ZONOVATE turoctocog alfa B02BD Parenteral/Powder for solution blank Within Guidelines
02435233 ZONOVATE turoctocog alfa B02BD Parenteral/Powder for solution blank Within Guidelines

O

Octapharma Canada Inc.
Octapharma Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02432951 NUWIQ - 250 IU/VIAL antihemophilic factor (recombinant, b-domain deleted) B02BD   Parenteral/Powder for solution Expired Within Guidelines
02432978 NUWIQ - 500 IU/VIAL antihemophilic factor (recombinant, b-domain deleted) B02BD  Parenteral/Powder for solution Expired Within Guidelines
02432986 NUWIQ - 1000 IU/VIAL antihemophilic factor (recombinant, b-domain deleted) B02BD  Parenteral/Powder for solution Expired Within Guidelines
02432994 NUWIQ - 2000 IU/VIAL antihemophilic factor (recombinant, b-domain deleted) B02BD  Parenteral/Powder for solution Expired Within Guidelines
02474050 NUWIQ - 3000 IU/VIAL antihemophilic factor (recombinant, b-domain deleted) B02BD  Parenteral/Powder for solution Expired Within Guidelines
02474069 NUWIQ - 4000 IU/VIAL antihemophilic factor (recombinant, b-domain deleted) B02BD   Parenteral/Powder for solution Expired Within Guidelines
Organon Canada Inc.
Organon Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02455331 BRENZYS - 50 MG/ML etanercept L04AB Parenteral/Solution blank Within Guidelines
02455323 BRENZYS - 50 MG/ML etanercept L04AB Parenteral/Solution blank Within Guidelines
02247521 EZETROL - 10 MG/TABLET ezetimibe C10AX Oral Solid/Tablet blank Within Guidelines
02473097 HADLIMA - 40 MG/SYRINGE adalimumab  L04AB Parenteral/Solution Introduced Within Guidelines
02473100 HADLIMA PUSH TOUCH - 40 MG/AUTO-INJECTOR adalimumab  L04AB Parenteral/Solution Introduced Within Guidelines
02374803 SAPHRIS - 5 MG/TABLET asenapine maleate N05AH Dental - Sublingual buccal/Sublingual tablet blank Does Not Trigger
02374811 SAPHRIS - 10 MG/TABLET asenapine maleate N05AH Dental - Sublingual buccal/Sublingual tablet blank Does Not Trigger
02247997 SINGULAIR - 4 MG/POUCH montelukast sodium R03DC Oral Solid/Effervescent granule blank Within Guidelines
Otsuka Canada Pharmaceutical Inc.
Otsuka Canada Pharmaceutical Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02322374 ABILIFY - 2 MG/TABLET aripiprazole N05AX Oral Solid/Tablet blank Within Guidelines
02322382 ABILIFY - 5 MG/TABLET aripiprazole N05AX Oral Solid/Tablet blank Within Guidelines
02322390 ABILIFY - 10 MG/TABLET aripiprazole N05AX Oral Solid/Tablet blank Within Guidelines
02322404 ABILIFY - 15 MG/TABLET aripiprazole N05AX Oral Solid/Tablet blank Does Not Trigger
02322412 ABILIFY - 20 MG/TABLET aripiprazole N05AX Oral Solid/Tablet blank Does Not Trigger
02322455 ABILIFY - 30 MG/TABLET aripiprazole N05AX Oral Solid/Tablet blank Does Not Trigger
02420864 ABILIFY MAINTENA - 300 MG/VIAL aripiprazole N05AX Parenteral/Suspension or Emulsion blank Within Guidelines
02420872 ABILIFY MAINTENA - 400 MG/VIAL aripiprazole N05AX Parenteral/Suspension or Emulsion blank Within Guidelines
02461749 REXULTI - 0.25 MG/TABLET brexpiprazole N05AX Oral Solid/Tablet blank Within Guidelines
02461757 REXULTI - 0.5 MG/TABLET brexpiprazole N05AX Oral Solid/Tablet blank Within Guidelines
02461765 REXULTI - 1 MG/TABLET brexpiprazole N05AX Oral Solid/Tablet blank Within Guidelines
02461773 REXULTI - 2 MG/TABLET brexpiprazole N05AX Oral Solid/Tablet blank Within Guidelines
02461781 REXULTI - 3 MG/TABLET brexpiprazole N05AX Oral Solid/Tablet blank Within Guidelines
02461803 REXULTI - 4 MG/TABLET brexpiprazole N05AX Oral Solid/Tablet blank Within Guidelines
02471574 VELPHORO - 500 MG/TABET sucroferric oxyhydroxide V03AE Oral Solid/Tablet (chewable) blank Does Not Trigger
02481359 VELTASSA - 8.4 G/SACHET patiromer sorbitex calcium V03AE Parenteral/Powder for suspension blank Does Not Trigger
02481367 VELTASSA - 16.8 G/SACHET patiromer sorbitex calcium V03AE Parenteral/Powder for suspension blank Within Guidelines

P

Paladin Labs Inc.
Paladin Labs Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02242980 ANTIZOL - 1 G/ML fomepizole V03AB Parenteral/Solution blank Subj. Investigation
02485877 ENVARSUS PA - 0.75 MG/TABLET tacrolimus L04AD   Oral Solid/Modified release tablet blank Does Not Trigger
02485885 ENVARSUS PA - 1 MG/TABLET tacrolimus L04AD  Oral Solid/Modified release tablet blank Does Not Trigger
02485893 ENVARSUS PA - 4 MG/TABLET tacrolimus L04AD Oral Solid/Modified release tablet blank Does Not Trigger
02257084 FROVA - 2.5 MG/TABLET frovatriptan succinate N02CC Oral Solid/Tablet blank Subj. Investigation
02437333 ICLUSIG - 15 MG/TABLET ponatinib hydrochloride L01XE Oral Solid/Tablet blank Subj. Investigation
02247698 METADOL - 1 MG/TABLET methadone hydrochloride N07BC Oral Solid/Tablet blank Within Guidelines
02247699 METADOL - 5 MG/TABLET methadone hydrochloride N07BC Oral Solid/Tablet blank Within Guidelines
02247700 METADOL - 10 MG/TABLET methadone hydrochloride N07BC Oral Solid/Tablet blank Within Guidelines
02247701 METADOL - 25 MG/TABLET methadone hydrochloride N07BC Oral Solid/Tablet blank Within Guidelines
02459132 MOVAPO - 10 MG/ML apomorphine hydrochloride N04BC Parenteral/Solution blank Does Not Trigger
02415577 NUCYNTA EXTENDED RELEASE - 50 MG/TABLET tapentadol hydrochloride N02AX Oral Solid/Modified release tablet blank Does Not Trigger
02415585 NUCYNTA EXTENDED RELEASE - 100 MG/TABLET tapentadol hydrochloride N02AX Oral Solid/Modified release tablet blank Does Not Trigger
02415593 NUCYNTA EXTENDED RELEASE - 150 MG/TABLET tapentadol hydrochloride N02AX Oral Solid/Modified release tablet blank Does Not Trigger
02415607 NUCYNTA EXTENDED RELEASE - 200 MG/TABLET tapentadol hydrochloride N02AX Oral Solid/Modified release tablet blank Does Not Trigger
02415615 NUCYNTA EXTENDED RELEASE - 250 MG/TABLET tapentadol hydrochloride N02AX Oral Solid/Modified release tablet blank Does Not Trigger
02378272 NUCYNTA IR - 50 MG/TABLET tapentadol hydrochloride N02AX Oral Solid/Tablet blank Within Guidelines
02378280 NUCYNTA IR - 75 MG/TABLET tapentadol hydrochloride N02AX Oral Solid/Tablet blank Does Not Trigger
02378299 NUCYNTA IR - 100 MG/TABLET tapentadol hydrochloride N02AX Oral Solid/Tablet blank Within Guidelines
02398257 SILENOR - 3 MG/TABLET doxepin N06AA Oral Solid/Tablet blank Does Not Trigger
02398265 SILENOR - 6 MG/TABLET doxepin N06AA Oral Solid/Tablet blank Does Not Trigger
02411849 VEREGEN - 100 MG/G sinecatechins D06BB Topical/Ointment blank Does Not Trigger
02516241 WAKIX - 5 MG/TABLET pitolisant N07XX Oral Solid/Tablet blank Under Review
02516268 WAKIX - 20 MG/TABLET pitolisant N07XX Oral Solid/Tablet blank Under Review
02480522 XYDALBA - 500 MG/VIAL dalbavancin J01XA Parenteral/Powder for solution blank Does Not Trigger
Partner Therapeutics Inc.
Partner Therapeutics Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
LEUKINE - 250 MCG/ML sargramostim L03AA Parenteral/Solution blank Subj. Investigation
Pediapharm Inc.
Pediapharm Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02459655 OTIXAL 3/0.25 MG/ML ciprofloxacin/flucinolone acetonide S02CA Otic/Solution blank Within Guidelines
Pfizer Canada ULC
Pfizer Canada ULC
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02232043 ARICEPT - 5 MG/TABLET donepezil hydrochloride N06DA Oral Solid/Tablet blank Within Guidelines
02232044 ARICEPT - 10 MG/TABLET donepezil hydrochloride N06DA Oral Solid/Tablet blank Within Guidelines
02269457 ARICEPT RDT - 5 MG/TABLET donepezil hydrochloride N06DA Oral Solid/Tablet blank Does Not Trigger
02269465 ARICEPT RDT - 10 MG/TABLET donepezil hydrochloride N06DA Oral Solid/Tablet blank Does Not Trigger
02242705 AROMASIN - 25 MG/TABLET exemestane L02BG Oral Solid/Tablet Expired Within Guidelines
02293773 BENEFIX - 500 UNIT/VIAL coagulation factor ix (recombinant) B02BD Parenteral/Powder for solution blank Does Not Trigger
02293781 BENEFIX - 1000 UNIT/VIAL coagulation factor ix (recombinant) B02BD Parenteral/Powder for solution blank Subj. Investigation
02293803 BENEFIX - 2000 UNIT/VIAL coagulation factor ix (recombinant) B02BD Parenteral/Powder for solution blank Subj. Investigation
02392984 BENEFIX - 3000 UNIT/VIAL coagulation factor ix (recombinant) B02BD Parenteral/Powder for solution blank Subj. Investigation
02473909 BESPONSA - 0.9 MG/VIAL inotuzumab ozogamicin L01XC Parenteral/Powder for solution blank Within Guidelines
02419149 BOSULIF - 100 MG/TABLET bosutinib L01XE Oral Solid/Tablet blank Subj. Investigation
02419157 BOSULIF - 500 MG/TABLET bosutinib L01XE Oral Solid/Tablet blank Within Guidelines
02513099 BRAFTOVI - 75 MG/CAPSULE encorafenib L01EC Oral Solid/Capsule Introduced Under Review
02291177 CHAMPIX - 0.5 MG/TABLET varenicline tartrate N07BA Oral Solid/Tablet blank Does Not Trigger
02291185 CHAMPIX - 1 MG/TABLET varenicline tartrate N07BA Oral Solid/Tablet blank Within Guidelines
02298309 CHAMPIX varenicline tartrate N07BA Oral Solid/Tablet blank Within Guidelines
02425637 ELELYSO - 200 IU/VIAL taliglucerase alpha A16AB Parenteral/Solution blank Within Guidelines
02476991 EUCRISA - 20 MG/G crisaborole D11AX Topical/Ointment blank Within Guidelines
02401762 GENOTROPIN - 0.6 MG/SYRINGE somatropin H01AC Parenteral/Powder for solution blank Does Not Trigger
02401770 GENOTROPIN - 0.8 MG/SYRINGE somatropin H01AC Parenteral/Powder for solution blank Within Guidelines
02401789 GENOTROPIN - 1 MG/SYRINGE somatropin H01AC Parenteral/Powder for solution blank Within Guidelines
02401797 GENOTROPIN - 1.2 MG/SYRINGE somatropin H01AC Parenteral/Powder for solution blank Within Guidelines
02401800 GENOTROPIN - 1.4 MG/SYRINGE somatropin H01AC Parenteral/Powder for solution blank Does Not Trigger
02401819 GENOTROPIN - 1.6 MG/SYRINGE somatropin H01AC Parenteral/Powder for solution blank Does Not Trigger
02401827 GENOTROPIN - 1.8 MG/SYRINGE somatropin H01AC Parenteral/Powder for solution blank Within Guidelines
02401835 GENOTROPIN - 2 MG/SYRINGE somatropin H01AC Parenteral/Powder for solution blank Within Guidelines
02401703 GENOTROPIN - 5.3 MG/PEN somatropin H01AC Parenteral/Powder for solution blank Within Guidelines
02401711 GENOTROPIN - 12 MG/PEN somatropin H01AC Parenteral/Powder for solution blank Within Guidelines
02401746 GENOTROPIN MINIQUICK - 0.2 MG/SYRINGE somatropin H01AC Parenteral/Powder for solution blank Within Guidelines
02401754 GENOTROPIN MINIQUICK - 0.4 MG/SYRINGE somatropin H01AC Parenteral/Powder for solution blank Within Guidelines
02493535 IBRANCE - 75 MG/TABLET palbociclib L01XE Oral Solid/Tablet blank Within Guidelines
02493543 IBRANCE - 100 MG/TABLET palbociclib L01XE Oral Solid/Tablet blank Within Guidelines
02493551 IBRANCE - 125 MG/TABLET palbociclib L01XE Oral Solid/Tablet blank Within Guidelines
02453150 IBRANCE - 75 MG/CAPSULE palbociclib L01XE Oral Solid/Capsule blank Within Guidelines
02453169 IBRANCE - 100 MG/CAPSULE palbociclib L01XE Oral Solid/Capsule blank Within Guidelines
02453177 IBRANCE - 125 MG/CAPSULE palbociclib L01XE Oral Solid/Capsule blank Within Guidelines
02389630 INLYTA - 1 MG/TABLET axitinib L01XE Oral Solid/Tablet blank Within Guidelines
02389649 INLYTA - 5 MG/TABLET axitinib L01XE Oral Solid/Tablet blank Within Guidelines
02485966 LORBRENA - 25 MG/TABLET lorlatinib L01XE Oral Solid/Tablet blank Within Guidelines
02485974 LORBRENA - 100 MG/TABLET lorlatinib L01XE Oral Solid/Tablet blank Within Guidelines
02513080 MEKTOVI - 15 MG/TABLET binimetinib L01EE Oral Solid/Tablet Introduced Under Review
02402904 NIMENRIX - 5 MCG/DOSE meningococcal polysaccharide groups a, c, w-135 and y conjugate vaccine J07AH Parenteral/Powder for solution blank Within Guidelines
02437147 PRECEDEX - 4 MCG/ML dexmedetomidine hydrochloride N05CM Parenteral/Solution blank Within Guidelines
02339366 PRECEDEX - 100 MCG/ML dexmedetomidine hydrochloride N05CM Parenteral/Solution blank Does Not Trigger
02335204 PREVNAR 13 - 0.5 ML/SYRINGE pneumococcal 13-valent conjugate vaccine J07AL Parenteral/Suspension or Emulsion blank Within Guidelines
02321092 PRISTIQ - 50 MG/TABLET desvenlafaxine succinate N06AX Oral Solid/Modified release tablet blank Subj. Investigation
02321106 PRISTIQ - 100 MG/TABLET desvenlafaxine succinate N06AX Oral Solid/Modified release tablet blank Subj. Investigation
02243237 RAPAMUNE - 1 MG/ML sirolimus L04AA Oral Liquid/Solution Expired Does Not Trigger
02247111 RAPAMUNE - 1 MG/TABLET sirolimus L04AA Oral Liquid/Solution Expired Subj. Investigation
02280795 SUTENT - 12.5 MG/CAPSULE sunitinib malate L01XE Oral Solid/Capsule blank Within Guidelines
02280809 SUTENT - 25 MG/CAPSULE sunitinib malate L01XE Oral Solid/Capsule blank Within Guidelines
02280817 SUTENT - 50 MG/CAPSULE sunitinib malate L01XE Oral Solid/Capsule blank Within Guidelines
02304104 TORISEL - 25 MG/VIAL temsirolimus L01XE Parenteral/Solution blank Does Not Trigger
02380021 TOVIAZ - 4 MG/TABLET fesoterodine fumarate G04BD Oral Solid/Modified release tablet blank Within Guidelines
02380048 TOVIAZ - 8 MG/TABLET fesoterodine fumarate G04BD Oral Solid/Modified release tablet blank Within Guidelines
02468751 TRUMENBA 60/60 neisseria meningitidis group b recombinant lipoprotein 2086 subfamily a/neisseria meningitidis group b recombinant lipoprotein 2088 subfamily b J07AH Parenteral/Suspension or Emulsion blank Does Not Trigger
02285401 TYGACIL - 50 MG/VIAL tigecycline J01AA Parenteral/Powder for solution blank Within Guidelines
02486024 VIZIMPRO - 15 MG/TABLET dacomitinib L01XE Oral Solid/Tablet blank Within Guidelines
02486040 VIZIMPRO - 45 MG/TABLET dacomitinib L01XE Oral Solid/Tablet blank Within Guidelines
02384256 XALKORI - 200 MG/CAPSULE crizotinib L01XE Oral Solid/Capsule blank Within Guidelines
02384264 XALKORI - 250 MG/CAPSULE crizotinib L01XE Oral Solid/Capsule blank Within Guidelines
02423898 XELJANZ - 5 MG/TABLET tofacitinib L04AA Oral Solid/Tablet blank Within Guidelines
02480786 XELJANZ - 10 MG/TABLET tofacitinib L04AA Oral Solid/Tablet blank Within Guidelines
02470608 XELJANZ XR - 11 MG/TABLET tofacitinib L04AA Oral Solid/Modified release tablet blank Within Guidelines
02309483 XYNTHA - 250 UNIT/VIAL moroctocog alfa B02BD Parenteral/Powder for solution blank Within Guidelines
02309491 XYNTHA - 500 UNIT/VIAL moroctocog alfa B02BD Parenteral/Powder for solution blank Within Guidelines
02374064 XYNTHA SOLOFUSE - 500 UNIT/SYRINGE moroctocog alfa B02BD Parenteral/Powder for solution blank Within Guidelines
02374072 XYNTHA SOLOFUSE - 1000 UNIT/SYRINGE moroctocog alfa B02BD Parenteral/Powder for solution blank Within Guidelines
02374080 XYNTHA SOLOFUSE - 2000 UNIT/SYRINGE moroctocog alfa B02BD Parenteral/Powder for solution blank Within Guidelines
02374099 XYNTHA SOLOFUSE - 3000 UNIT/SYRINGE moroctocog alfa B02BD Parenteral/Powder for solution blank Within Guidelines
02223716 ZITHROMAX - 20 MG/ML azithromycin J01FA Oral Liquid/Powder for suspension blank Does Not Trigger
02223724 ZITHROMAX - 40 MG/ML azithromycin J01FA Oral Liquid/Powder for suspension blank Subj. Investigation
02212021 ZITHROMAX - 250 MG/TABLET azithromycin J01FA Oral Solid/Tablet blank Does Not Trigger
02239952 ZITHROMAX IV - 500 MG/VIAL azithromycin J01FA Parenteral/Powder for solution blank Does Not Trigger
02243685 ZYVOXAM - 2 MG/ML linezolid J01XX Parenteral/Solution Expired Does Not Trigger
02243686 ZYVOXAM - 20 MG/ML linezolid J01XX Oral Liquid/Powder for suspension Expired Does Not Trigger
02243684 ZYVOXAM - 600 MG/TABLET linezolid J01XX Oral Solid/Tablet Expired Does Not Trigger
Pierre Fabre Dermo-Cosmétique Canada Inc.
Pierre Fabre Dermo-Cosmétique Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02457857 HEMANGIOL - 3.75 MG/ML propranolol hydrochloride C07AA Oral Liquid/Solution blank Within Guidelines
Purdue Pharma
Purdue Pharma
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02231934 OXY-IR - 5 MG/TABLET oxycodone hydrochloride N02AA Oral Solid/Tablet blank Does Not Trigger
02240131 OXY-IR - 10 MG/TABLET oxycodone hydrochloride N02AA Oral Solid/Tablet blank Does Not Trigger
02240132 OXY-IR - 20 MG/TABLET oxycodone hydrochloride N02AA Oral Solid/Tablet blank Within Guidelines
02372525 OXYNEO - 10 MG/TABLET oxycodone hydrochloride N02AA Oral Solid/Modified release tablet blank Within Guidelines
02372533 OXYNEO - 15 MG/TABLET oxycodone hydrochloride  N02AA Oral Solid/Modified release tablet blank Within Guidelines
02372797 OXYNEO - 20 MG/TABLET oxycodone hydrochloride N02AA Oral Solid/Modified release tablet blank Within Guidelines
02372541 OXYNEO - 30 MG/TABLET oxycodone hydrochloride  N02AA Oral Solid/Modified release tablet blank Within Guidelines
02372568 OXYNEO - 40 MG/TABLET oxycodone hydrochloride N02AA Oral Solid/Modified release tablet blank Within Guidelines
02372576 OXYNEO - 60 MG/TABLET oxycodone hydrochloride N02AA Oral Solid/Modified release tablet blank Within Guidelines
02372584 OXYNEO - 80 MG/TABLET oxycodone hydrochloride  N02AA Oral Solid/Modified release tablet blank Within Guidelines
02387425 TARGIN 5/2.5 MG/TABLET oxycodone hydrochloride/naloxone hydrochloride N02AA Oral Solid/Modified release tablet blank Does Not Trigger
02339609 TARGIN 10/5 MG/TABLET oxycodone hydrochloride/naloxone hydrochloride N02AA Oral Solid/Modified release tablet blank Does Not Trigger
02339617 TARGIN 20/10 MG/TABLET oxycodone hydrochloride/naloxone hydrochloride N02AA Oral Solid/Modified release tablet blank Within Guidelines
02339625 TARGIN 40/20 MG/TABLET oxycodone hydrochloride/naloxone hydrochloride N02AA Oral Solid/Modified release tablet blank Within Guidelines

R

Recordati Rare Diseases
Recordati Rare Diseases
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02516764 LEDAGA - 160 MCG/G chlormethine hydrochloride L01AA Topical/Gel blank Subj. Investigation
02413299 SIGNIFOR - 0.3 MG/ML pasireotide H01CB Parenteral/Solution blank Within Guidelines
02413302 SIGNIFOR - 0.6 MG/ML pasireotide H01CB Parenteral/Solution blank Within Guidelines
02413310 SIGNIFOR - 0.9 MG/ML pasireotide H01CB Parenteral/Solution blank Within Guidelines
02480425 SIGNIFOR LAR - 10 MG/VIAL pasireotide H01CB Parenteral/Powder for suspension blank Within Guidelines
02437252 SIGNIFOR LAR - 20 MG/VIAL pasireotide H01CB Parenteral/Powder for solution blank Within Guidelines
02480433 SIGNIFOR LAR - 30 MG/VIAL pasireotide H01CB Parenteral/Powder for suspension blank Within Guidelines
02437260 SIGNIFOR LAR - 40 MG/VIAL pasireotide H01CB Parenteral/Powder for solution blank Does Not Trigger
02437279 SIGNIFOR LAR - 60 MG/VIAL pasireotide H01CB Parenteral/Powder for solution blank Does Not Trigger

S

Sandoz Canada Inc.
Sandoz Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02246533 ANGIOMAX - 250 MG/VIAL bivalirudin B01AE Parenteral/Powder for solution blank Subj. Investigation
Sanofi Genzyme, A Division of Sanofi-Aventis Canada Inc.
Sanofi Genzyme, A Division of Sanofi-Aventis Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02463261 CERDELGA - 84 MG/CAPSULE eliglustat A16AX Oral Solid/Capsule blank Subj. Investigation
Sanofi Pasteur Ltd
Sanofi Pasteur Ltd
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02279924 MENACTRA meningococcal polysaccharide diphtheria toxoid conjugate vaccine J07AH Parenteral/Solution blank Within Guidelines
Sanofi-Aventis Canada Inc.
Sanofi-Aventis Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02464276 ADLYXINE - 0.05 MG/ML lixisenatide A10BJ Parenteral/Solution blank Does Not Trigger
02464284 ADLYXINE - 0.1 MG/ML lixisenatide A10BJ Parenteral/Solution blank Does Not Trigger
02422913 ALPROLIX - 500 IU/VIAL coagulation factor ix (recombinant), fc fusion protein B02BD Parenteral/Powder for solution blank Within Guidelines
02422921 ALPROLIX - 1000 IU/VIAL coagulation factor ix (recombinant), fc fusion protein B02BD Parenteral/Powder for solution blank Subj. Investigation
02422948 ALPROLIX - 2000 IU/VIAL coagulation factor ix (recombinant), fc fusion protein B02BD Parenteral/Powder for solution blank Subj. Investigation
02422956 ALPROLIX - 3000 IU/VIAL coagulation factor ix (recombinant), fc fusion protein B02BD Parenteral/Powder for solution blank Within Guidelines
02279460 APIDRA - 100 UNIT/ML insulin glulisine A10AB Parenteral/Solution blank Within Guidelines
02279479 APIDRA - 100 UNIT/ML insulin glulisine A10AB Parenteral/Solution blank Within Guidelines
02294346 APIDRA SOLOSTAR - 100 UNIT/ML insulin glulisine A10AB Parenteral/Solution blank Within Guidelines
02378582 CAPRELSA - 100 MG/TABLET vandetanib L01XE Oral Solid/Tablet blank Within Guidelines
02378590 CAPRELSA - 300 MG/TABLET vandetanib L01XE Oral Solid/Tablet blank Within Guidelines
02330407 CLOLAR - 20 MG/VIAL clofarabine L01BB Parenteral/Solution Expired Does Not Trigger
02492504 DUPIXENT - 200 MG/SYRINGE dupilumab D11AH Parenteral/Solution blank Within Guidelines
02470365 DUPIXENT - 300 MG/SYRINGE dupilumab D11AH Parenteral/Solution blank Within Guidelines
02510049 DUPIXENT - 300 MG/AUTO-INJECTOR dupilumab D11AH  Parenteral/Solution Introduced Subj. Investigation
02430304 ELOCTATE - 500 IU/VIAL antihemophilic factor (recombinant bdd), fc fusion protein B02BD Parenteral/Powder for solution blank Within Guidelines
02430312 ELOCTATE - 750 IU/VIAL antihemophilic factor (recombinant bdd), fc fusion protein B02BD Parenteral/Powder for solution blank Within Guidelines
02430320 ELOCTATE - 1000 IU/VIAL antihemophilic factor (recombinant bdd), fc fusion protein B02BD Parenteral/Powder for solution blank Subj. Investigation
02430339 ELOCTATE - 1500 IU/VIAL antihemophilic factor (recombinant bdd), fc fusion protein B02BD Parenteral/Powder for solution blank Within Guidelines
02430347 ELOCTATE - 2000 IU/VIAL antihemophilic factor (recombinant bdd), fc fusion protein B02BD Parenteral/Powder for solution blank Does Not Trigger
02430355 ELOCTATE - 3000 IU/VIAL antihemophilic factor (recombinant bdd), fc fusion protein B02BD Parenteral/Powder for solution blank Within Guidelines
02460521 KEVZARA - 150 MG/SYRINGE sarilumab L04AC Parenteral/Solution blank Within Guidelines
02472961 KEVZARA - 150 MG/PEN sarilumab L04AC Parenteral/Solution blank Within Guidelines
02460548 KEVZARA - 200 MG/SYRINGE sarilumab L04AC Parenteral/Solution blank Within Guidelines
02472988 KEVZARA - 200 MG/PEN sarilumab L04AC Parenteral/Solution blank Within Guidelines
02245689 LANTUS - 100 UNIT/ML insulin glargine A10AE Parenteral/Solution blank Within Guidelines
02251930 LANTUS - 100 UNIT/ML insulin glargine A10AE Parenteral/Solution blank Subj. Investigation
02294338 LANTUS SOLOSTAR - 100 UNIT/ML insulin glargine A10AE Parenteral/Solution blank Within Guidelines
02377225 MOZOBIL - 20 MG/ML plerixafor L03AX Parenteral/Solution blank Within Guidelines
02284863 MYOZYME - 50 MG/VIAL alglucosidase alfa A16AB Parenteral/Powder for solution Expired Within Guidelines
02453819 PRALUENT - 75 MG/ML alirocumab C10AX Parenteral/Solution blank Within Guidelines
02453835 PRALUENT - 150 MG/ML alirocumab C10AX Parenteral/Solution blank Within Guidelines
02498235 SARCLISA - 100 MG/VIAL isatuximab L01XC Parenteral/Solution blank Within Guidelines
02498243 SARCLISA - 500 MG/VIAL isatuximab L01XC Parenteral/Solution blank Within Guidelines
02478293 SOLIQUA - 3 ML/PEN insuline glargine/lixisenatide A10AE Parenteral/Solution blank Does Not Trigger
02493373 TOUJEO DOUBLESTAR - 300 UNIT/ML insulin glargine A10AE Parenteral/Solution blank Within Guidelines
02441829 TOUJEO SOLOSTAR - 300 UNIT/ML insulin glargine A10AE Parenteral/Solution blank Within Guidelines
Santen SAS
Santen SAS
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02484137 VERKAZIA - 1 MG/ML cyclosporine S01XA Ophthalmic/Other blank Within Guidelines
Seagen Canada Inc.
Seagen Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02401347 ADCETRIS - 50 MG/VIAL brentuximab vedotin L01XC Parenteral/Powder for solution Expired Within Guidelines
02499827 TUKYSA - 50 MG/TABLET tucatinib L01EH Oral Solid/Tablet blank Subj. Investigation
02499835 TUKYSA - 150 MG/TABLET tucatinib L01EH Oral Solid/Tablet blank Subj. Investigation
Searchlight Pharma Inc.
Searchlight Pharma Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02273217 ENABLEX - 7.5 MG/TABLET darifenacin G04BD Oral Solid/Tablet blank Within Guidelines
02273225 ENABLEX - 15 MG/TABLET darifenacin G04BD Oral Solid/Tablet blank Within Guidelines
02513218 NEXTSTELLIS 15/3 MG/TABLET estetrol monohydrate and drospirenone G03AA Oral Solid/Tablet Introduced Under Review
Seqirus Canada Inc.
Seqirus Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02362384 FLUAD - 45 MCG/DOSE influenza vaccine, surface antigen, inactivated J07BB Parenteral/Suspension or Emulsion blank Subj. Investigation
Servier Canada Inc.
Servier Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
BELEODAQ - 500 MG/VIAL belinostat L01XX Parenteral/Powder for solution blank Within Guidelines
02356422 DIAMICRON MR - 60 MG/TABLET gliclazide A10BB Oral Solid/Modified release tablet blank Within Guidelines
02481820 FOLOTYN - 20 MG/ML pralatrexate L01BA Parenteral/Solution blank Within Guidelines
02459973 LANCORA - 5 MG/TABLET ivabradine C01EB Oral Solid/Tablet blank Within Guidelines
02459981 LANCORA - 75 MG/TABLET ivabradine C01EB Oral Solid/Tablet blank Within Guidelines
02458640 LIXIANA - 15 MG/TABLET edoxaban B01AF Oral Solid/Tablet blank Within Guidelines
02458659 LIXIANA - 30 MG/TABLET edoxaban B01AF Oral Solid/Tablet blank Within Guidelines
02458667 LIXIANA - 60 MG/TABLET edoxaban B01AF Oral Solid/Tablet blank Within Guidelines
02467135 ONIVYDE - 4.3 MG/ML irinotecan hydrochloride trihydrate L01XX Parenteral/Suspension or Emulsion blank Within Guidelines
02451530 VIACORAM 3.5/2.5 MG/TABLET perindopril arginine/amlodipine besylate C09BB Oral Solid/Tablet Expired Within Guidelines
02451549 VIACORAM 7/5 MG/TABLET perindopril arginine/amlodipine besylate C09BB Oral Solid/Tablet Expired Within Guidelines
02451557 VIACORAM 14/10 MG/TABLET perindopril arginine/amlodipine besylate C09BB Oral Solid/Tablet Expired Within Guidelines
SpringWorks Therapeutics Inc.
SpringWorks Therapeutics Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
NIROGACESTAT - 10 MG/TABLET nirogacestat blank Oral Solid/Tablet Introduced Under Review
NIROGACESTAT - 50 MG/TABLET nirogacestat blank Oral Solid/Tablet Introduced Under Review
NIROGACESTAT - 100 MG/TABLET nirogacestat blank Oral Solid/Tablet Introduced Under Review
SteriMax Inc.
SteriMax Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02130181 PROLEUKIN - 22000000 UNIT/VIAL aldesleukin L03AC Parenteral/Powder for solution blank Within Guidelines
Sun Pharmaceutical Industries Inc.
Sun Pharmaceutical Industries Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02512629 CEQUA - 0.9 MG/ML cyclosporine S01XA Ophthalmic/Solution Introduced Under Review
02516098 ILUMYA - 100 MG/ML tildrakizumab L04AC Parenteral/Solution blank Under Review
02500337 ODOMZO - 200 MG/CAPSULE sonidegib L01XX Oral Solid/Capsule blank Subj. Investigation
Sunovion Pharmaceuticals Canada Inc.
Sunovion Pharmaceuticals Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02426862 APTIOM - 200 MG/TABLET eslicarbazepine acetate N03AF Oral Solid/Tablet blank Within Guidelines
02426870 APTIOM - 400 MG/TABLET eslicarbazepine acetate N03AF Oral Solid/Tablet blank Within Guidelines
02426889 APTIOM - 600 MG/TABLET eslicarbazepine acetate N03AF Oral Solid/Tablet blank Within Guidelines
02426897 APTIOM - 800 MG/TABLET eslicarbazepine acetate N03AF Oral Solid/Tablet blank Within Guidelines
02465493 CUBICIN RF - 500 MG/VIAL daptomycin J01XX Parenteral/Powder for solution blank Within Guidelines
02500264 KYNMOBI - 10 MG/FILM apomorphine hydrochloride N04BC Oral Solid/Film (soluble) blank Within Guidelines
02500272 KYNMOBI - 15 MG/FILM apomorphine hydrochloride N04BC Oral Solid/Film (soluble) blank Within Guidelines
02500280 KYNMOBI - 20 MG/FILM apomorphine hydrochloride N04BC Oral Solid/Film (soluble) blank Within Guidelines
02500299 KYNMOBI - 25 MG/FILM apomorphine hydrochloride N04BC Oral Solid/Film (soluble) blank Within Guidelines
02500302 KYNMOBI - 30 MG/FILM apomorphine hydrochloride N04BC Oral Solid/Film (soluble) blank Within Guidelines
02422050 LATUDA - 20 MG/TABLET lurasidone hydrochloride N05AE Oral Solid/Tablet blank Does Not Trigger
02387751 LATUDA - 40 MG/TABLET lurasidone hydrochloride N05AE Oral Solid/Tablet blank Within Guidelines
02413361 LATUDA - 60 MG/TABLET lurasidone hydrochloride N05AE Oral Solid/Tablet blank Within Guidelines
02387778 LATUDA - 80 MG/TABLET lurasidone hydrochloride N05AE Oral Solid/Tablet blank Within Guidelines
02387786 LATUDA - 120 MG/TABLET lurasidone hydrochloride N05AE Oral Solid/Tablet blank Within Guidelines
Swedish Orphan Biovitrum, SOBI AB
Swedish Orphan Biovitrum, SOBI AB
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
GAMIFANT - 10 MG/VIAL emapalumab-lzsg L04AA Parenteral/Solution blank Subj. Investigation
02245913 KINERET - 100 MG/SYRINGE anakinra L04AA Parenteral/Solution blank Within Guidelines
02469693 ORFADIN - 4 MG/ML nitisinone A16AX Oral Liquid/Suspension blank Within Guidelines
02459698 ORFADIN - 2 MG/CAPSULE nitisinone A16AX Oral Solid/Capsule blank Subj. Investigation
02459701 ORFADIN - 5 MG/CAPSULE nitisinone A16AX Oral Solid/Capsule blank Subj. Investigation
02459728 ORFADIN - 10 MG/CAPSULE nitisinone A16AX Oral Solid/Capsule blank Subj. Investigation
02459736 ORFADIN - 20 MG/CAPSULE nitisinone A16AX Oral Solid/Capsule blank Within Guidelines

T

Taiho Pharma Canada
Taiho Pharma Canada
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02501600 INQOVI 35/100 MG/TABLET decitabine/cedazuridine L01BC Oral Solid/Tablet blank Subj. Investigation
02472104 LONSURF 15/6.14 MG/TABLET trifluridine/tipiracil L01BC Oral Solid/Tablet blank Subj. Investigation
02472112 LONSURF 20/8.19 MG/TABLET trifluridine/tipiracil L01BC Oral Solid/Tablet blank Subj. Investigation
Takeda Canada Inc.
Takeda Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02248808 ADDERALL XR - 5 MG/CAPSULE mixed salts amphetamine  N06BA Oral Solid/Modified release capsule blank Within Guidelines
02248809 ADDERALL XR - 10 MG/CAPSULE mixed salts amphetamine  N06BA Oral Solid/Modified release capsule blank Within Guidelines
02248810 ADDERALL XR - 15 MG/CAPSULE mixed salts amphetamine  N06BA Oral Solid/Modified release capsule blank Within Guidelines
02248811 ADDERALL XR - 20 MG/CAPSULE mixed salts amphetamine  N06BA Oral Solid/Modified release capsule blank Within Guidelines
02248812 ADDERALL XR - 25 MG/CAPSULE mixed salts amphetamine  N06BA Oral Solid/Modified release capsule blank Within Guidelines
02248813 ADDERALL XR - 30 MG/CAPSULE mixed salts amphetamine N06BA Oral Solid/Modified release capsule blank Within Guidelines
02459035 ADYNOVATE - 250 IU/VIAL antihemophilic factor (recombinant), pegylated B02BD Parenteral/Powder for solution blank Within Guidelines
02498537 ADYNOVATE - 250 IU/VIAL antihemophilic factor (recombinant), pegylated B02BD Parenteral/Powder for solution Introduced Under Review
02459043 ADYNOVATE - 500 IU/VIAL antihemophilic factor (recombinant), pegylated B02BD Parenteral/Powder for solution blank Within Guidelines
02498545 ADYNOVATE - 500 IU/VIAL antihemophilic factor (recombinant), pegylated B02BD Parenteral/Powder for solution Introduced Under Review
02459051 ADYNOVATE - 1000 IU/VIAL antihemophilic factor (recombinant), pegylated B02BD Parenteral/Powder for solution blank Within Guidelines
02498588 ADYNOVATE - 1000 IU/VIAL antihemophilic factor (recombinant), pegylated B02BD Parenteral/Powder for solution Introduced Under Review
02459078 ADYNOVATE - 2000 IU/VIAL antihemophilic factor (recombinant), pegylated B02BD Parenteral/Powder for solution blank Subj. Investigation
02498626 ADYNOVATE - 3000 IU/VIAL antihemophilic factor (recombinant), pegylated B02BD Parenteral/Powder for solution blank Within Guidelines
02479206 ALUNBRIG - 30 MG/TABLET brigatinib L01XE Oral Solid/Tablet blank Within Guidelines
02479214 ALUNBRIG - 90 MG/TABLET brigatinib L01XE Oral Solid/Tablet blank Within Guidelines
02479222 ALUNBRIG - 180 MG/TABLET brigatinib L01XE Oral Solid/Tablet blank Within Guidelines
02479230 ALUNBRIG 90/180 MG/PACK brigatinib L01XE Oral Solid/Tablet blank Within Guidelines
02354950 DEXILANT - 30 MG/CAPSULE dexlansoprazole A02BC Oral Solid/Capsule blank Subj. Investigation
02354969 DEXILANT - 60 MG/CAPSULE dexlansoprazole A02BC Oral Solid/Capsule blank Within Guidelines
02497867 ENTYVIO - 108 MG/SYRINGE vedolizumab L04AA Parenteral/Solution blank Within Guidelines
02497875 ENTYVIO - 108 MG/SYRINGE vedolizumab L04AA Parenteral/Powder for solution blank Within Guidelines
02436841 ENTYVIO - 300 MG/VIAL vedolizumab L04AA Parenteral/Powder for solution blank Within Guidelines
02287145 FOSRENOL - 250 MG/TABLET lanthanum carbonate hydrate V03AE Oral Solid/Tablet blank Within Guidelines
02287153 FOSRENOL - 500 MG/TABLET lanthanum carbonate hydrate V03AE Oral Solid/Tablet blank Within Guidelines
02287161 FOSRENOL - 750 MG/TABLET lanthanum carbonate hydrate V03AE Oral Solid/Tablet blank Within Guidelines
02287188 FOSRENOL - 1000 MG/TABLET lanthanum carbonate hydrate V03AE Oral Solid/Tablet blank Does Not Trigger
02206021 IMMUNINE VH factor ix coagulation B02BD Parenteral/Powder for solution blank Within Guidelines
02409100 INTUNIV XR - 1 MG/TABLET guanfacine hydrochloride  C02AC Oral Solid/Modified release tablet Expired Within Guidelines
02409119 INTUNIV XR - 2 MG/TABLET guanfacine hydrochloride  C02AC Oral Solid/Modified release tablet Expired Within Guidelines
02409127 INTUNIV XR - 3 MG/TABLET guanfacine hydrochloride  C02AC Oral Solid/Modified release tablet Expired Within Guidelines
02409135 INTUNIV XR - 4 MG/TABLET guanfacine hydrochloride C02AC Oral Solid/Modified release tablet Expired Within Guidelines
02417219 KAZANO 12.5/500 MG/TABLET alogliptin benzoate/metformin hydrochloride A10BD Oral Solid/Tablet blank Within Guidelines
02417227 KAZANO 12.5/850 MG/TABLET alogliptin benzoate/metformin hydrochloride A10BD Oral Solid/Tablet blank Does Not Trigger
02417235 KAZANO 12.5/1000 MG/TABLET alogliptin benzoate/metformin hydrochloride A10BD Oral Solid/Tablet blank Within Guidelines
02417189 NESINA - 6.25 MG/TABLET alogliptin benzoate A10BH Oral Solid/Tablet blank Within Guidelines
02417197 NESINA - 12.5 MG/TABLET alogliptin benzoate A10BH Oral Solid/Tablet blank Within Guidelines
02417200 NESINA - 25 MG/TABLET alogliptin benzoate A10BH Oral Solid/Tablet blank Within Guidelines
02456796 NINLARO - 2.3 MG/CAPSULE ixazomib citrate L01XX Oral Solid/Capsule blank Within Guidelines
02456818 NINLARO - 3 MG/CAPSULE ixazomib citrate L01XX Oral Solid/Capsule blank Within Guidelines
02456826 NINLARO - 4 MG/CAPSULE ixazomib citrate L01XX Oral Solid/Capsule blank Within Guidelines
02447401 OBIZUR - 500 UNIT/ML antihemophilic factor (recombinant), porcine sequence B02BD Parenteral/Powder for solution blank Subj. Investigation
02389983 ONDISSOLVE ODF - 4 MG/FILM ondansetron A04AA Oral Solid/Film (soluble) blank Within Guidelines
02389991 ONDISSOLVE ODF - 8 MG/FILM ondansetron A04AA Oral Solid/Film (soluble) blank Within Guidelines
02241804 PANTOLOC - 20 MG/TABLET pantoprazole sodium A02BC Oral Solid/Tablet blank Does Not Trigger
02229453 PANTOLOC - 40 MG/TABLET pantoprazole sodium A02BC Oral Solid/Tablet blank Within Guidelines
02249057 REPLAGAL - 250 IU/VIAL agalsidase alfa A16AB Parenteral/Solution blank Within Guidelines
02445727 REVESTIVE - 5 MG/VIAL teduglutide A16AX Oral Liquid/Powder for solution blank Within Guidelines
02431939 RIXUBIS - 500 UNIT/VIAL nonacog gamma B02BD Parenteral/Powder for solution blank Does Not Trigger
02431947 RIXUBIS - 1000 UNIT/VIAL nonacog gamma B02BD Parenteral/Powder for solution blank Does Not Trigger
02431955 RIXUBIS - 2000 UNIT/VIAL nonacog gamma B02BD Parenteral/Powder for solution blank Subj. Investigation
02431963 RIXUBIS - 3000 UNIT/VIAL nonacog gamma B02BD Parenteral/Powder for solution blank Subj. Investigation
02505614 TAKHZYRO - 150 MG/ML lanadelumab B06AC Parenteral/Solution Introduced Within Guidelines
02480948 TAKHZYRO - 150 MG/ML lanadelumab B06AC Parenteral/Solution blank Within Guidelines
02267233 TECTA - 40 MG/TABLET pantoprazole magnesium A02BC Oral Solid/Tablet blank Within Guidelines
02357380 ULORIC - 80 MG/TABLET febuxostat M04AA Oral Solid/Tablet blank Within Guidelines
02357119 VPRIV - 400 UNIT/VIAL velaglucerase alfa A16AB Parenteral/Powder for solution blank Within Guidelines
02490226 VYVANSE - 10 MG/TABLET lisdexamfetamine dimesylate N06BA Oral Solid/Tablet (chewable) blank Within Guidelines
02490234 VYVANSE - 20 MG/TABLET lisdexamfetamine dimesylate N06BA Oral Solid/Tablet (chewable) blank Within Guidelines
02490242 VYVANSE - 30 MG/TABLET lisdexamfetamine dimesylate N06BA Oral Solid/Tablet (chewable) blank Within Guidelines
02490250 VYVANSE - 40 MG/TABLET lisdexamfetamine dimesylate N06BA Oral Solid/Tablet (chewable) blank Within Guidelines
02490269 VYVANSE - 50 MG/TABLET lisdexamfetamine dimesylate N06BA Oral Solid/Tablet (chewable) blank Does Not Trigger
02490277 VYVANSE - 60 MG/TABLET lisdexamfetamine dimesylate N06BA Oral Solid/Tablet (chewable) blank Does Not Trigger
02439603 VYVANSE - 10 MG/CAPSULE lisdexamfetamine dimesylate N06BA Oral Solid/Capsule blank Within Guidelines
02347156 VYVANSE - 20 MG/CAPSULE lisdexamfetamine dimesylate N06BA Oral Solid/Capsule blank Within Guidelines
02322951 VYVANSE - 30 MG/CAPSULE lisdexamfetamine dimesylate N06BA Oral Solid/Capsule blank Within Guidelines
02347164 VYVANSE - 40 MG/CAPSULE lisdexamfetamine dimesylate N06BA Oral Solid/Capsule blank Within Guidelines
02322978 VYVANSE - 50 MG/CAPSULE lisdexamfetamine dimesylate N06BA Oral Solid/Capsule blank Within Guidelines
02347172 VYVANSE - 60 MG/CAPSULE lisdexamfetamine dimesylate N06BA Oral Solid/Capsule blank Within Guidelines
02458071 VYVANSE - 70 MG/CAPSULE lisdexamfetamine dimesylate N06BA Oral Solid/Capsule blank Subj. Investigation
Teva Canada Innovation G.P.-S.E.N.C.
Teva Canada Innovation G.P.-S.E.N.C.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02467895 AERMONY RESPICLICK - 55 MCG/ACTUATION fluticasone propionate R03BA Pulmonary/Powder (metered dose) blank Within Guidelines
02467909 AERMONY RESPICLICK - 113 MCG/ACTUATION fluticasone propionate R03BA Pulmonary/Powder (metered dose) blank Within Guidelines
02467917 AERMONY RESPICLICK - 232 MCG/ACTUATION fluticasone propionate R03BA Pulmonary/Powder (metered dose) blank Within Guidelines
02497859 AJOVY - 225 MG/SYRINGE fremanezumab N02CD Parenteral/Solution blank VCU
02509474 AJOVY - 225 MG/AUTO-INJECTOR fremanezumab N02CD Parenteral/Solution Introduced VCU
02245619 COPAXONE - 20 MG/SYRINGE glatiramer acetate L03AX Parenteral/Solution blank Within Guidelines
02456915 COPAXONE - 40 MG/ML glatiramer acetate L03AX Parenteral/Solution blank Within Guidelines
02408007 FENTORA - 100 MCG/TABLET fentanyl citrate N02AB Dental - Sublingual buccal/Sublingual tablet blank Subj. Investigation
02408015 FENTORA - 200 MCG/TABLET fentanyl citrate N02AB Dental - Sublingual buccal/Sublingual tablet blank Does Not Trigger
02408023 FENTORA - 400 MCG/TABLET fentanyl citrate N02AB Dental - Sublingual buccal/Sublingual tablet blank Does Not Trigger
02408031 FENTORA - 600 MCG/TABLET fentanyl citrate N02AB Dental - Sublingual buccal/Sublingual tablet blank Does Not Trigger
02408058 FENTORA - 800 MCG/TABLET fentanyl citrate N02AB Dental - Sublingual buccal/Sublingual tablet blank Does Not Trigger
02346176 SEASONIQUE 0.15/0.03-0.01 levonorgestrel/ethinyl estradiol + ethinyl estradiol G03AA Oral Solid/Tablet blank Within Guidelines
Theratechnologies Inc.
Theratechnologies Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02438712 EGRIFTA - 1 MG/VIAL tesamorelin H01AC Parenteral/Powder for solution blank Within Guidelines

U

UCB Canada Inc.
UCB Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02452987 BRIVLERA - 10 MG/ML brivaracetam N03AX Oral Liquid/Solution blank Within Guidelines
02452995 BRIVLERA - 10 MG/ML brivaracetam N03AX Parenteral/Solution blank Within Guidelines
02452936 BRIVLERA - 10 MG/TABLET brivaracetam N03AX Oral Solid/Tablet blank Within Guidelines
02452944 BRIVLERA - 25 MG/TABLET brivaracetam N03AX Oral Solid/Tablet blank Within Guidelines
02452952 BRIVLERA - 50 MG/TABLET brivaracetam N03AX Oral Solid/Tablet blank Within Guidelines
02452960 BRIVLERA - 75 MG/TABLET brivaracetam N03AX Oral Solid/Tablet blank Within Guidelines
02452979 BRIVLERA - 100 MG/TABLET brivaracetam N03AX Oral Solid/Tablet blank Within Guidelines
02331675 CIMZIA - 200 MG/ML certolizumab pegol L04AB Parenteral/Powder for solution Expired Within Guidelines
02465574 CIMZIA - 200 MG/ML certolizumab pegol L04AB Parenteral/Powder for solution Expired Within Guidelines
02403897 NEUPRO - 1 MG/PATCH rotigotine N04BC Topical/Patch blank Within Guidelines
02403900 NEUPRO - 2 MG/PATCH rotigotine N04BC Topical/Patch blank Within Guidelines
02403919 NEUPRO - 3 MG/PATCH rotigotine N04BC Topical/Patch blank Within Guidelines
02403927 NEUPRO - 4 MG/PATCH rotigotine N04BC Topical/Patch blank Within Guidelines
02403935 NEUPRO - 6 MG/PATCH rotigotine N04BC Topical/Patch blank Within Guidelines
02403943 NEUPRO - 8 MG/PATCH rotigotine N04BC Topical/Patch blank Within Guidelines
02357666 VIMPAT - 10 MG/ML lacosamide N03AX Parenteral/Solution blank Within Guidelines
02357615 VIMPAT - 50 MG/TABLET lacosamide N03AX Oral Solid/Tablet blank Within Guidelines
02357623 VIMPAT - 100 MG/TABLET lacosamide N03AX Oral Solid/Tablet blank Within Guidelines
02357631 VIMPAT - 150 MG/TABLET lacosamide N03AX Oral Solid/Tablet blank Within Guidelines
02357658 VIMPAT - 200 MG/TABLET lacosamide N03AX Oral Solid/Tablet blank Within Guidelines
Ultragenyx Pharmaceuticals Inc.
Ultragenyx Pharmaceuticals Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02483629 CRYSVITA - 10 MG/ML burosumab M05BX Parenteral/Solution blank VCU
02483637 CRYSVITA - 20 MG/ML burosumab M05BX Parenteral/Solution blank VCU
02483645 CRYSVITA - 30 MG/ML burosumab M05BX Parenteral/Solution blank VCU
02512556 DOJOLVI - 1000 MG/ML triheptanoin A16AX Oral Liquid/Liquid Introduced Does Not Trigger
Upjohn Canada ULC
Upjohn Canada ULC
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02239064 DETROL - 1 MG/TABLET tolterodine tartrate G04BD Oral Solid/Tablet blank Does Not Trigger
02239065 DETROL - 2 MG/TABLET tolterodine tartrate G04BD Oral Solid/Tablet blank Does Not Trigger
02244612 DETROL LA - 2 MG/CAPSULE tolterodine l-tartrate G04BD Oral Solid/Modified release capsule blank Does Not Trigger
02244613 DETROL LA - 4 MG/CAPSULE tolterodine l-tartrate G04BD Oral Solid/Modified release capsule blank Within Guidelines

V

Valeo Pharma Inc.
Valeo Pharma Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02498685 ATECTURA BREEZHALER 150/80 MG/CAPSULE indacaterol acetate/mometasone furoate R03AK Pulmonary/Powder blank Subj. Investigation
02498707 ATECTURA BREEZHALER 150/160 MG/CAPSULE indacaterol acetate/mometasone furoate R03AK Pulmonary/Powder blank Subj. Investigation
02498693 ATECTURA BREEZHALER 150/320 MG/CAPSULE indacaterol acetate/mometasone furoate R03AK Pulmonary/Powder blank Does Not Trigger
02501244 ENERZAIR BREEZHALER 150/50/160 MG/CAPSULE indacaterol acetate/glycopyrronium bromide/mometas one furoate R03AL Pulmonary/Powder blank Subj. Investigation
02484641 ONSTRYV - 50 MG/TABLET safinamide N04BD Oral Solid/Tablet blank Within Guidelines
02484668 ONSTRYV - 100 MG/TABLET safinamide N04BD Oral Solid/Tablet blank Within Guidelines
02351528 YONDELIS - 1 MG/VIAL trabectedin L01CX Parenteral/Powder for solution blank Does Not Trigger
Vertex Pharmaceuticals Canada Inc.
Vertex Pharmaceuticals Canada Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02519364 KALYDECO - 25 MG/PACK ivacaftor R07AX Oral Solid/Granules Introduced Under Review
02442612 KALYDECO - 50 MG/PACK ivacaftor R07AX Oral Solid/Effervescent granule blank Within Guidelines
02442620 KALYDECO - 75 MG/PACK ivacaftor R07AX Oral Solid/Effervescent granule blank Within Guidelines
02397412 KALYDECO - 150 MG/TABLET ivacaftor R07AX Oral Solid/Tablet blank Within Guidelines
02483831 ORKAMBI 100/125 MG/GRANULE lumacaftor/ivacaftor R07AX Oral Solid/Granule blank Subj. Investigation
02463040 ORKAMBI 125/100 MG/TABLET lumacaftor/ivacaftor R07AX Oral Solid/Tablet blank Subj. Investigation
02483858 ORKAMBI 150/188 MG/GRANULE lumacaftor/ivacaftor R07AX Oral Solid/Granule blank Subj. Investigation
02451379 ORKAMBI 200/125 MG/TABLET lumacaftor/ivacaftor R07AX Oral Solid/Tablet blank Subj. Investigation
02478080 SYMDEKO 100/150; 150 tezacaftor/ivacaftor and ivacaftor R07AX Oral Solid/Tablet blank Within Guidelines
02517140 TRIKAFTA elexacaftor/tezacaftor/ivacaftor and ivacaftor R07AX Oral Solid/Tablet blank Under Review
ViiV Healthcare ULC
ViiV Healthcare ULC
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02497220 CABENUVA 200/300 - 1000 MG/KIT cabotegravir/rilpivirine J05AR Parenteral/Kit blank Within Guidelines
02497247 CABENUVA 200/300 - 1500 MG/KIT cabotegravir/rilpivirine J05AR Parenteral/Kit blank Within Guidelines
02299844 CELSENTRI - 150 MG/TABLET maraviroc J05AX Oral Solid/Tablet Expired Does Not Trigger
02299852 CELSENTRI - 300 MG/TABLET maraviroc J05AX Oral Solid/Tablet Expired Does Not Trigger
02491753 DOVATO 50/300 MG/TABLET dolutegravir/lamivudine J05AR Oral Solid/Tablet blank Within Guidelines
02475774 JULUCA 50/25 MG/TABLET dolutegravir/rilpivirine J05AR Oral Solid/Tablet blank Within Guidelines
02269341 KIVEXA 300/600 - 900 MG/TABLET abacavir sulfate/lamivudine J05AF Oral Solid/Tablet Expired Subj. Investigation
02461218 TIVICAY - 10 MG/TABLET dolutegravir J05AX Oral Solid/Tablet blank Does Not Trigger
02461226 TIVICAY - 25 MG/TABLET dolutegravir J05AX Oral Solid/Tablet blank Does Not Trigger
02414945 TIVICAY - 50 MG/TABLET dolutegravir J05AX Oral Solid/Tablet blank Within Guidelines
02430932 TRIUMEQ 50/600/300 MG/TABLET dolutegravir/abacavir/lamivudine  J05AR Oral Solid/Tablet blank Within Guidelines
02497204 VOCABRIA - 30 MG/TABLET cabotegravir J05AR Oral Solid/Tablet blank Within Guidelines

X

Xediton Pharmaceuticals Inc.
Xediton Pharmaceuticals Inc.
DIN Brand Name Medicinal Ingredient ATC Dosage Comments Status
02242367 VISUDYNE - 15 MG/VIAL verteporfin L01XX Parenteral/Powder for solution blank Within Guidelines

* Does not include medicines introduced or patented in December 2021.

Page details

Date modified: